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Abstract 
 
Mutations in genes of various intermediate filament (IF) proteins are the causes of a wide 
range of diseases. For example, a premature aging disorder, Hutchinson-Gilbert progeria 
syndrome, is caused by mutation in the nuclear lamins. Mutations in a muscle-specific IF 
protein desmin cause a wide range of myofibrillar myopathies, and in severe cases 
cardiomyopathies. The effects of the desmin mutations vary with respect to the severity of 
their impact on its filament formation capacity. One of the observations on the tissue sections 
of the patients includes the occurrence of both apparently normal association of desmin 
filaments with Z-discs as well as the occurrence of desmin accumulations in the muscle cells 
of patients. However, the exact mechanisms leading to such phenotype remain unknown. 
The purpose of this PhD thesis was to analyse the effects of some of the known desmin 
mutations on cell differentiation. In addition, considering what appears to be concurrent 
occurrence of desmin aggregation and IFs formation as indicated above we aimed to 
determine to what extent are normal and mutant desmin proteins segregated in these cells. For 
that purpose, we have employed C2C12 murine myoblast cell line for analyses of the impacts 
of desmin mutantions. As these cells can be induced to differentiate they are commonly used 
as a model in studies on muscle cells. Therefore, we have transfected genes of the normal 
human desmin (hDesWT) and some known desmin mutants into these cells. In order to detect 
the transfected protein antibodies specific for hDes were generated. 
Two desmin gene mutations were used for the analyses, namely hDesE245D and hDesR350P. 
Whereas the former desmin mutant was found to be incorporated into the IF-system of 
fibroblasts, the later segregates from it and accumulates in small aggregates through the cell. 
The analyses performed included cell fractionation and immuno-cytochemistry. hDesWT and 
hDesE245D mutant were predominantly found to incorporate into endogenous desmin IFs, 
whereas the extent of hDesR350P mutant incorporation into the filaments varied in the cell 
population. By subsequent cell passaging the number of hDesR350P-expressing cells was 
reduced, whereas both hDesWT and hDesE245D were still expressed to a similar extent.  
Subsequently transfected C2C12 cells were induced to differentiate. Similarly to the 
observations in cell passaging, the amount of hDesR350P but not hDesWT or hDesE245D in 
cells was found to be reduced upon differentiation. Expression of a myosin heavy chain, a 
C2C12 differentiation marker, was higher in cells expressing either of the mutants than in 
untransfected or the cells transfected with the hDesWT desmin. Finally, the transfected cells 
were subjected to immuno-cytochemical analyses with respect to the coexpression of myosin 
heavy chain and of the various transfected desmins. Whereas hDesWT and hDesE245D were 
both present in approximately 70% of myosin heavy chain positive cells, about 10% of 
differentiating cells contained hDesR350P.  
Additional studies on C2C12 cells included the analyses of distribution of the A-type lamins 
in undifferentiated and differentiated cells. Whereas in the undifferentiated C2C12 cells some 
soluble A-type lamins could have been extracted, the differentiated cells appeared to contain 
very little of such lamins. Furthermore, the A-type lamin distribution in cells transfected with 
hDesR350P, but not hDesWT or hDesE245D, and subjected to differentiation was the same as 
in myoblasts, indicating the cells likely fail to undergo differentiation. These results 
demonstrate a very close connection between cytosolic and nuclear IFs. Finally, they indicate 
that the late onset of desminopathies could be correlated to the steady hDesR350P clearance 
from the cultured myoblasts leading to their failure of cells to differentiate.  
 
 
Zusammenfassung 
 
Mutationen in Genen, die für eines der vielen Intermediärfilament-(IF)-Proteine kodieren, 
sind die Ursache für eine Vielzahl humaner Erkrankungen. Mutationen im muskelspezifischen 
IF-Protein Desmin verursachen myofibrillärer Myopathien und in schweren Fällen auch 
Cardiomyopathien (Desminopathien). Sind nukleäre IF-Proteine wie die Lamine betroffen, so 
beobachtet man ein breites Spektrum von Erkrankungen, und zwar ebenfalls 
Muskeldystrophien und Cardiomyopathien aber auch systemische Erkrankungen wie die 
vorzeitigen Alterung oder Progerie. Die verschiedenen Desmin-Mutationen unterscheiden 
sich hinsichtlich der Schwere ihrer Auswirkungen auf die Fähigkeit des Proteins, geordnete 
Filamente zu bilden. Übereinstimmend mit dieser aus in vitro-Experimenten gewonnenen 
Erkenntnis beobachtet man auf Gewebeschnitten von Patienten das massive Auftreten von 
Desmin-Aggregaten sowie eine umfassende strukturelle Degeneration der Sarkomere. Die 
zugrunde liegenden Pathomechanismen sind weitestgehend nicht bekannt. 
Das Ziel dieser Doktorarbeit war es daher, die Auswirkungen einiger der signifikanten 
Desmin-Mutationen auf die Muskelzell-Differenzierung zu analysieren. Frühere Studien 
hatten gezeigt, dass Desmin-Aggregate und IFs nebeneinander in Myotuben auftreten können. 
Daher war es unser Ziel, zu ermitteln in welchem Umfang normales und mutiertes Desmin in 
Muskelzellen in gemeinsamen Strukturen auftauchen oder ob sie teilweise oder vollständig 
segregieren. Zu diesem Zweck haben wir die Maus-Zelllinie C2C12, die von Myoblasten 
abgeleitet ist und die sich in Kultur zu Myotuben differenzieren lässt, zur Analyse der 
Desmin-Mutanten eingesetzt. Um normales humanes Desmin (hDesWT) und von ihm 
abgeleitete Mutanten nach Transfektion in C2C12-Zellen von endogenem Desmin 
unterscheiden zu können, haben wir einen für humanes Desmin spezifischen Antikörper 
erzeugt.  
Als beispielhafte Mutanten haben wir hDesE245D und hDesR350P gewählt. Die erstere 
inkorporiert in das IF-System von Fibroblasten, die letztere segregiert vollständig und lagert 
sich in Form kleiner Aggregate ab. In C2C12-Zellen war das Ergebnis deutlich anders: 
während hDesE245D wie hDesWT nach Transfektion in endogene IFs inkorporiert wurde, 
war das Auftreten von hDesR350P in unterschiedlichen Zellen einer Kultur sehr variabel. Als 
wichtigstes Ergebnis aber erhielten wir, dass die Expression von hDesR350P im Verlauf 
nachfolgender Passagen fast vollständig verloren ging - ganz im Gegensatz zu der von 
hDesWT und hDesE245D, die relativ stabil exprimiert wurden.  
An diese Experimente anschließend wurden transfizierte C2C12-Zellen zur Differenzierung 
angeregt. Ähnlich zu den Beobachtungen während der fortgesetzten Kultur nicht 
differenzierender Zellen, wurde die Menge von hDesR350P, nicht aber die von hDesWT und 
von hDesE245D, in den Zellen während der Differenzierung stark reduziert. Dieser Befund 
deutet darauf hin, dass die Gegenwart von hDesR350P in den Zellen die Differenzierung 
behindert. Dagegen war die Expression der schweren Kette des Myosins (MHC), einem 
Differenzierungsmarker für C2C12-Zellen, höher in mit den Mutanten als in den mit hDesWT 
transfizierten Zellen. Weiterhin, während hDesWT und hDesE245D in etwa 70% der MHC-
positiven Zellen gefunden wurde, enthielten weniger als 10% der differenzierenden Zellen 
hDesR350. Basierend auf diesen Beobachtungen mit C2C12-Zellen, könnte man vermuten, 
dass auch in Patienten bestimmte mutierte Desmin-Varianten die zelluläre Homöostase 
deutlicher stören als andere und daher zu einem früheren Beginn der Erkrankung führen. 
Schließlich deutet eine andere Beobachtung, die veränderte Menge an Lamin A im 
Nukleoplasma als Folge der Anwesenheit mutierter Desmine, auf einen weiteren Aspekt des 
Pathomechanismus hin, und zwar könnte die Expressionskontrolle einiger Gene durch 
Reduktion der Menge nukleoplasmatischen Lamins langfristig gestört werden und somit zur 
Entwicklung einer Desminopathie führen. 
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1. Introduction 
1.1 Intermediate filaments 
 
1.1.1 Different filamentous networks in a cell 
The eukaryotic cytoskeleton represents an elaborate system of filaments, which integrates the 
cellular organelles into a coordinated system. It primarily consists out of three distinct 
network types: microfilaments (MFs), microtubules (MTs) and intermediate filaments (IFs). 
The three filament systems are in addition supported by a large number of associated proteins. 
Actin and tubulin, which represent principal components of the MFs and MTs respectively, 
are globular subunits existing in three primary isoforms, α, β, and γ. They are found in cells of 
all eukaryotic organisms and play a major role in cell contraction and motility, in case of 
MFs, or represent a transport scaffold for trafficking of various cellular components, as in 
case of MTs. IFs, on the other hand, which are coded by over 70 genes as in case of humans, 
are characterised by common domain organisation albeit with high differences in their amino 
acid composition (Herrmann and Aebi 2004).  
 
1.1.2 Abundance of the IF proteins 
Unlike MFs or MTs, which are found throughout the eukaryotic kingdom, IFs are restricted to 
metazoan cells. The name for IFs stems from their filaments diameter of ~10-12 nm which is 
intermediate to that of MFs (~5-8 nm) and MTs (~20-25 nm). As such, they have been 
initially observed in the 1960s upon analysis of metaphase myocytes as filament structures 
which stained negative for actin and myosin (Ishikawa et al. 1968). The three distinct filament 
systems can be distinguished by electron microscopy (EM) or immunofluorescence 
microscopy in different myogenic cultured cells (Franke et al. 1978).  
 
Most metazoans exhibit two distinct IF systems: cytosolic and nucleoplasmic. Cytosolic IFs 
span the cytoplasm whereby they connect various plasma membrane-associated complexes, 
such as desmosomes and hemidesmosomes in epithelial cells, or costamers and intercalated 
discs in striated cardiac muscle. On the other hand, nucleoplasmic IF networks span the 
chromatin being located primarily adjacent to the inner nuclear membrane (INM). Their main 
components are the lamins (Herrmann et al. 2007). Nuclear lamina, a meshwork of lamins, 
further integrates INM proteins, nuclear pores and heterochromatin into a joint functional 
surface. The lamina network remains stable throughout the cell cycle, except during mitosis 
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when the nuclear envelope opens up and lamins are phosphorylated leading to their dispersion 
throughout the cytosol.  
 
1.1.3 Structure of the IF proteins 
As indicated above, members of the IF superfamily share their domain organisation. Namely, 
they exhibit a tripartite structure, consisting of a central α-helical “rod” domain flanked by a 
non-α-helical amino-terminal “head” and a carboxy-terminal “tail” domain (Geisler et al. 
1982). The α-helix of the rod domain consists out of four subdomains, namely 1A, 1B, 2A 
and 2B, which are connected by non-α-helical linkers, L1 and L12, as well as the helical L2 
linker (the model is depicted on figure 1A). The length of the α-helical subdomains is 
conserved to the very amino acid among vertebrate cytoplasmic IFs.  
 
In addition, the α-helical domain consists out of seven-residue (heptad) repeat with a short 
discontinuity in the 2B subdomain, the so called “stutter” (Parry 2005). The heptad repeats 
further leads to the formation of coiled-coil dimers of two IF polypeptides (figure 1B), which 
represent the building blocks of the IF assembly. The coiled-coil dimmers of IF proteins also 
exhibit a high stability in buffers containing high concentrations of salt or detergents, 
indicating that their tight association is likely mediated by a combination of hydrophobic and 
ionic interactions (Steinert and Roop 1988). 
 
A
B
 
Figure 1. Domain organisation of IF proteins. (A) Scheme of the domain organisation of 
desmin as an example of an IF protein: the predominantly α-helical rod domain, flanked by 
largely unstructured head and tail domains. The rod domain of consists of pre-coil domain 
(PCD, only in vimentin-like IF proteins – marked by yellow box), coils 1A, 1B, 2A and 2B, 
as well as the linker segments between them: L1, L12 and L2. IF consensus motifs (CD) are 
marked with red boxes as well as the stutter (st) in the coild 2B. (B) Model of the dimeric 
coiled-coil structure as exhibited by vimentin (adapted from Herrmann et al. 2009). 
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1.1.4 Different classes of the IF proteins 
As previously mentioned, there are over 70 different genes coding for IF proteins, as well as 
some alternatively spliced variants of the genes. Whereas actin and tubulin are abundant in 
many different cell types IF proteins are expressed in tissue- and development-specific 
manner. Based on their amino acid sequences comparison vertebrate IF proteins have been 
classified into six sequence homology classes (SHCs): SHC1 and SHC2 consist of acidic and 
basic keratins, respectively; SHC3 includes vimentin, desmin, glial fibrillary acidic protein 
(GFAP), and peripherin; neurofilament triplet proteins, as well as α-internexin and nestin 
comprise SHC4; SCH5 includes lamins; and SCH6 consists of beaded filament structural 
protein 1 (Bfsp1, also known as filensin) and Bsfp2 (also known as phakinin or CP49), two 
lens-specific proteins (Parry and Steinert 1999). The six SHCs could be further grouped based 
on their assembly properties, whereby keratins (SHC1 and SHC2 IF proteins, group 1), 
vimentin-like IFs (SHC3 and SHC4 IF proteins, group 2) and lamins (SCH5 IF proteins, 
group 3) represent the further three groups of the IF proteins. Members of each group are 
capable of forming heteropolymers (Herrmann and Aebi 2000).  
 
1.1.5 Assembly of the IFs 
The above outlined groups of IF proteins, based on similarities in their coil 2 sequences, 
further indicate their abilities to co-polymerise (Herrmann and Aebi 2000). On the other hand, 
the differences in their coil 1 segments allow them to segregate one from the other into 
distinct IF networks in a cell. In case of the first group of IFs, acidic and basic keratins are 
obligate heterodimers, i.e., one acidic and one basic type of keratins are required to form a 
keratin IF dimer. On the other hand, muscle, mesenchymal and neuronal IFs (group 2) could 
form both homo- and heteropolymers. For example, during the development of myocytes 
vimentin in those cells is steadily replaced by desmin IFs. Thereby, as the vimentin IFs are 
typical mesenchymal filaments, during myocyte maturation they are transiently coexpressed 
with desmin (Granger and Lazarides 1980). In addition, it has been experimentally 
demonstrated that vimentin and desmin filaments could form heteropolymers in vitro 
(Wickert et al. 2005), which has also been found to occur in vivo in hamster kidney cells 
(Quinlan and Franke 1982). Finally, lamins do not copolymerase with any of the other IF 
proteins.  
 
Unlike actin or tubulin, IF proteins bind neither ATP nor GTP during filament assembly 
(Pollard and Borisy 2003, Waterman-Storer and Salmon, 1997). In further contrast to MFs 
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and MTs IF structures are apolar due to the mode of assembly of proteins into the 
corresponding filaments. Based on in vitro studies with vimentin, used as a paradigmatic 
model for the mode of IF assembly, three distinct stages of IF assembly could have been 
discerned (figure 2). In the first stage of the in vitro assembly, vimentin would be 
reconstituted from 8 M urea into low-salt buffer to form relatively uniform tetrameric 
complexes of antiparallel, half-staggered coiled-coil dimmers. Subsequently by increasing 
ionic strength of the buffer, on average eight tetramers associate laterally into unit-length 
filaments (ULFs). In the following phase ULFs would first longitudinally anneal to form short 
filaments which could further associate into longer IFs.  In the last stage of the IF formation, 
long filaments would reduce their diameter by radial filament compaction, eventually giving 
rise to mature IFs.  
 
 
Figure 2. Scheme of the three major phases of the cytoplasmic IF assembly. In the phase 
1, eight tetrameric subunits made from two antiparallel, half-staggered coil-coiled dimmers 
associate laterally to form unit-length filaments (ULFs). In pahse 2, ULFs longitudinally 
anneal thereby steadily creating longer filaments. In the last phase, filaments would radially 
compact to yield mature filaments. Each vimentin molecule is represented by a single 
cylinder; coil 1 is dark red and coil 2 is yellow (adapted from Herrmann et al. 2009). 
 
1.2 Myocytes and IF-associated diseases 
 
1.2.1 IF networks in myocytes 
Striated muscle is composed of mature muscle cells, or myotubes, spanned by repeating 
sections of sarcomeres, which represent their contractile units characterised by a striated 
distribution of their proteins (Sanger and Sanger 2008). Skeletal myotubes arise by 
differentiation from myoblasts through the process of cell fusion. They have a complex of 
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plasma membrane proteins that connect the extra-cellular matrix with the cell cytoskeleton. 
IFs are the major cytoskeleton component that regulates cellular plasticity and signal 
transduction from the plasma membrane down to the chromatin. Through Z-discs, sarcomeres 
are connected to the plasma and nuclear membranes via desmin IFs (figure 3). 
 
Sarcomere
 
Figure 3. Scheme depicting role of the desmin IFs in maintaining skeletal muscle 
integrity. Desmin IFs (blue) interact with associated proteins to generate myofibre support. 
Different plectin isoforms (1, 1b, 1d and 1f) are also depicted to bridge the desmin IF 
connections to the nucleus, mitochondria, Z-discs and, in subsarcolemmal region 
(costameres), to dystrophin-glycoprotein complex (DGC). The scheme was adapted from 
Konieczny et al. 2008.  
 
Desmin (Greek desmos denotes a link or a bond) is the key IF protein found in cardiac, 
skeletal and smooth muscle cells (Lazarides 1980). It is one of the earliest muscle-specific 
markers that occur during development (Herrmann et al 1989). As they span the entire muscle 
cell, desmin IFs connect the plasma membrane, sarcomere, mitochondria and nuclei via 
different plectin isoforms, as well as other bridging proteins such as nestins. In addition, via 
plectin and different inner and outer nuclear membrane (ONM) proteins, such as SUNs and 
nesprins, desmin filaments are connected to the nuclear lamins. Therefore, they could be said 
to further bridge the link from the plasma membrane down to the chromatin (figure 4) and 
thereby create a uniform and coordinated filamentous network in the myocytes. 
 
Other types of non muscle-specific IFs found in myocytes include synemin and paranemin 
(Titeux et al. 2001, Schweitzer et al. 2001), both of which are found primarily around the Z 
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discs (Bellin et al. 2001). Another class of prominent muscle IF proteins are the nuclear 
lamins, predominantly found adjacent to the INM. In adult mammalian cells, lamins exist in 
four major isoforms: lamin A and lamin C (A-type lamins), which are coded by the same gene 
but are generated by alternative splicing; and lamin B1 and B2, which are products of two 
separate genes (Gruenbaum et al. 2005). In addition, whereas A-type lamins were also found 
to form speckles throughout the nucleoplasm in myoblasts, they appear to be largely lamina-
incorporated upon differentiation (Muralikrishna et al. 2001).  
 
 
Figure 4. Protein complexes spanning the nuclear envelope of mammalian cells. Through 
plectin, IFs are bound to nesprin-3, and via its link to SUN2 they are connected to the nuclear 
lamins (adapted from Wilhelmsen et al. 2006).  
 
1.2.2 Myofibrillar myopathies  
Considering the tissue-specific expression of most of the IF proteins, there is a wide range of 
tissue-specific diseases that could originate due to mutations in various IF proteins (the 
database of the diseases can be found at http://www.interfil.org/). For example, mutations in 
various keratins cause skin blistering diseases whereas mutations in GFAP or neurofilament 
proteins lead to Alexander’s disease or Charcot-Marie-Tooth disease, respectively (discussed 
in Herrmann and Aebi 2000). On the other hand, Hutchinson-Gilbert progeria syndrome 
(HGPS), a rare premature aging disorder, is caused by mutations in A-type lamins and 
therefore affects most of the tissues.  
 
One group of diseases, myofibrillar myopathies (MFMs), are caused by mutations in desmin, 
as well as other sarcomeric and extra-sarcomeric proteins. These proteins include plectin, 
titin, filamein-C and αB-crystallin, the chaperone associated with desmin filaments, as well as 
lamin A (Schröder and Schoser 2009). Apart from being caused by mutations in various extra-
myofibrillar and myofibrillar proteins, these diseases are clinically quite heterogeneous. 
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Nevertheless, the most prominent characteristic of these diseases is myofibrillar degeneration. 
In addition to the high variability in symptoms or degree of progression, most of the MFM 
patients have an adult onset of the disease, beyond the fourth decade of their lives.  
 
1.2.3 Desminopathies 
Desminopathies (synonyms: desmin-related myopathy, desmin myopathy, desmin storage 
myopathy, Selcen et al. 2004) are a subgroup of MFMs which are caused by mutations in 
desmin and tend to manifest themselves already in early and middle adulthood. In rare cases, 
the disease phenotype is already evident in the first decade of life (for example: Goldfarb et 
al. 1998). Clinically the diseases primarily manifest themselves with distal skeletal muscle 
dystrophies. Further clinical phenotypes include cardiomyopathies which may precede, 
coincide with or succeed the skeletal muscle weakness and, in some cases, respiratory 
insufficiencies (van Spaendonck-Zwarts et al. 2010).  
 
Another prominent characteristic of these diseases is the co-occurrence of desmin-enriched 
accumulations throughout the myofibres with preserved desmin IF pattern at the level of their 
Z-discs (figure 5A). In particular, one case analysed in greater detail was the severe desmin 
arginine (R) 350 to proline (P) (denoted as DesR350P) mutation, which is considered to be 
one of the most frequently found desmin missense mutations in Germany with a founder 
allele already established (Bär et al. 2005a, Walter et al. 2007). By analysing the muscle 
biopsies from patients baring that mutation in greater detail, the segregation of desmin 
deposits from the fully formed myofibre Z-discs was observed (figure 5B). Hence one of the 
key questions that arose from the studies with desmin disease mutants was to what extent are 
the mutant and the normal (i.e., wild type, WT) desmin proteins segregated in a cell. 
 
1.3 Objectives 
 
1.3.1 Background of the Study 
The large majority of mutations leading to desminopathies have been found in the coil 2B of 
the α-helical rod domain of desmin (Bär et al. 2006, figure 6A). However, these mutants have 
also been previously found to vary with respect to the severity of the disease phenotype. In 
one of the earlier studies by Bär et al. (2005b), some of the known mutations found in coils 
2B and 1B were categorised in vitro based on the stage at which they affect desmin filament 
assembly (figure 6B). In case of in vivo experiments, the mutants were primarily analysed in 
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the vimentin- and desmin-free SW13 cell line (e.g. Bär 2005b) or vimentin-possitive but 
desmin-negative 3T3 fibroblast cells (Bär 2005a). In order to investigate the effects of the 
mutations in the desminWT background, as well as the address the question of mutant and 
WT desmin segregation, the analysis of these mutants was done in a cell line stably 
expressing desmin. 
 
 
A B
 
Figure 5. Muscle architecture in desminopathy patients. (A) Immunofluorescence 
microscopy image of isolated myofibre from a desminopathy patient stained for desmin (red). 
One can clearly observe the large deposits of desmin accumulates in parallel with a typical 
staining pattern of preserved desmin filaments intersecting the preserved Z-discs. Scale bar, 
50 μm (B) Ultrastructural analysis of muscle fibre from desminoapthy patient carrying a 
DesR350P mutation, with pronounced aggregation of filament granules (left side of the 
image). Scale bar, 0.5 μm. The figures are adapted from Herrmann et al. 2007 and Bär et al. 
2005a. 
 
 
A common cell culture system employed in studies of myocyte biology is the C2C12 murine 
embryonic myoblast cell line (first isolated and described by Yaffe and Sexel 1977) which 
could be induced to differentiate by culturing the cells in serum-poor medium. Thereby, in 
addition the fact that they endogenously express desmin, these cells are a suitable system for 
the indicated analyses as one could study the effects of the mutants on cell differentiation.  
 
Finally, in order to be able to specifically detect the transfected mutant or WT desmin in the 
mouse desminWT background we have transfected human desmin (hDes) gene  variants of 
the WT and respective mutant proteins into the mouse cells. Human and mouse desmin 
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sequences differ in 12 out of total 470 amino acids (appendix 2). Therefore, we have also 
attempted to generate human and mouse desmin (mDes)-specific antibodies to able to 
differentiate the transfected (i.e. WT or mutant) desmin from the endogenous one.  
 
 
Figure 6. Some of the prominent mutations causing desminopathies. (A) Scheme of the 
desmin molecule (domain organisation as in figure 1A) with the prominent mutations mainly 
in coil 2B, as well as 1B, denoted. Lengths of each of the sequence segments are indicated 
(adapted from Bär et al. 2006). Mutations are colour coded based on the severity of the 
mutation as indicated in figure 6B. (B) Hypothetical scheme of desmin in vitro assembly (as 
in figure 2). The mutations indicated above are ordered with respect to the earliest stage in 
filament assembly when their effects could be detected in vitro (image adapted from Bär et al. 
2005b).  
 
1.3.2 Aims of the Work 
The aims of the work were to determine the effects of some desmin mutations on myoblasts 
differentiation and thereby analyse the amounts and distribution of the A-type lamins, as well 
as that of both transfected and the total desmin. Therefore the following was performed:  
1) C2C12 cells cultured in the growth or differentiation medium were characterised 
with respect to the indicated IF proteins.  
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2) The same analyses were performed in C2C12 cells stably transfected with 
hDesWT as well as two desmin mutants, hDesR350P and hDesE245D (figure 6).  
3) Further analyses were performed on C2C12 cells stably expressing the respective 
hDes proteins and which were induced to differentiate.  
4) In addition, to address the question of desmin mutant segregation from the DesWT 
the immunoprecipitation (IP) of the transfected protein was performed, as well as 
the analyses of colocalisation of vimentin and either endogenous or transfected 
desmin.  
5) Finally, the scope of the work involved the analyses of the antibodies which were 
generated, i.e. the h/mDes-specific ones, with a focus on examining their 
specificity.  
In order to perform the above indicated analyses the in vitro cell fractionation and subsequent 
Western blotting (WB), as well as immuno-cytochemistry (ICC) experiments were performed 
on the respective cells. 
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2. Materials and Methods 
2.1 Materials 
 
2.1.1 List of Chemicals 
Acrylamide (30%)       Roth 
Boric acid, H3BO3        Sigma-Aldrich 
Chrome-sulphuric acid (H2SO4 / CrO3)    NeoLab 
Digitonin        Aldrich 
Ethanol (CH3CH2OH)      Sigma-Aldrich 
Ethylenediaminetetraacetic acid (EDTA)    Sigma 
Ethylene glycol tetraacetic acid (EGTA)    Sigma 
Gylcine        Sigma 
Genetic Technology Grade (GTG) agarose     Biozym 
Hydrochloric acid (HCl)      Sigma-Aldrich  
Low Electroendosmosis (LE) agarose     Biozym 
3-(N-morpholino)propanesulfonic acid (MOPS)   Gerbu 
Magnesium sulphate heptahydrate (MgSO4 *7 H2O)  NeoLab 
Nonyl phenoxypolyethoxylethanol (NP40)    Sigma 
Phenylmethylsulfonyl fluoride (PMSF)    Serva 
Potsssium chloride, KCl      Roth 
Potassium dihydrogen phosphate, KH2PO4     Roth 
Sodium chloride, NaCl      Sigma 
Sodium dodecyl sulfate (SDS)      Fluka 
Sodium hydroxide (NaOH)       Riedel-de Haën 
Sodium phosphate dibasic dihydrate, Na2HPO4 x 2 H2O   Riedel-de Haën 
Tris(hydroxymethyl)aminomethane (Tris)    Sigma 
Triton X-100     Gerbu 
Polysorbate 20 (Tween 20)       Gerbu 
Urea         Serva 
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2.1.2 Primary Antibodies 
Below are listed the primary antibodies used in the experimental procedures. The standard 
dilutions (both in WB and ICC) are also indicated. 
 
Antibody  Epitope  Dilution in Dilution in Source 
      ICC  WB 
 
anti-desmin ms in the tail domain 1: 100  1: 2000 Progen, 
monoAb (D9)  of human desmin     #10519 
anti-hDes rb  TTRTPSSYGA     Generated and  
polyAb (HD1) in head domain of 1: 200  1: 10 000 purified by PSL  
   hDes       GmbH, Heidelberg 
anti-mDes rb  GFGTKGSSSSMTS     Generated and  
polyAb (MD1) in head domain of  (as indicated)  purified by PSL  
   hDes       GmbH, Heidelberg 
anti-mDes rb  PGFSLGSP      Generated and  
polyAb (MD2) in head domain of  (as indicated)  purified by PSL 
   hDes       GmbH, Heidelberg 
anti-DesWT rb GGMRQMREL     Generated and  
polyAb (HD2) in coil 2B of   (as indicated)  purified by PSL 
   hDes       GmbH, Heidelberg 
anti-DesR350P GGMRQMPEL     Generated and  
rb polyAb  in coil 2B of   (as indicated)  purified by PSL 
(HD350P)  hDes       GmbH, Heidelberg 
laminA/C ms  L1 subdomain of 1: 5  1: 10  generated in  
monoAb (LaZ) human LaminA/C     collaboration with 
                    H. Zentgraf, DKFZ 
DesminCT  C-terminal  1: 100  not used Epitomics 
Rabbit monoAb  tail domain      Clone Y66 
GAPDH ms  unknown  not used 1: 5000 Calbiochem 
monoAb (6C5)        Cat. No. CB1001 
mCherry ms   unknown  1: 500  not used GeneCopoeia, 
monoAb (OmicsLink)        CGAB-RFP-0050 
myosin heavy chain unknown  1: 100  1: 500  R&D Systems, 
monoAb ms (MF20)        MAB4470 
Vimentin 3B4 arc2 rod domain,  1: 200  not used Progen, 
1-13 ms monoAb coil 2       #65113 
VimentinCT  C-terminal  1: 100  not used Epitomics, 
rabbit monoAb tail domain      EPR3776 
 
2.1.3 Primers 
 Desmin01_for  GAGAGATCCGGAATGTCCCAGGCCTACTCGTC 
 Desmin01_rev AGAGAGCTCGAGTTAGAGCACTTCATGCTGC 
 DesminE245D_for CTTAAGAAAGTGCATGACGAGGAGATCCGTGAGTTG 
 DesminE245D_rev  CAACTCACGGATCTCCTCGTCATGCACTTTCTTAAG 
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DesminR350P_for CTGATGAGGCAGATGCCGGAATTGGAGGACCG 
 DesminR350P_rev CGGTCCTCCAATTCCGGCATCTGCCTCATCAG 
 
2.1.4 Plasmids (Clones)  
 pHβAPr-1-neo vector containing the rat β actin promoter, geneticin resistance  
    (described in Gunning et al. 1987) 
 p163/7   vector with an MHC promoter, no drug resistance  
 pIRES_mCherry contains internal ribosome entry site (IRES) of  
encephalomyocarditis virus (ECMV) with mCherry cloned in 
C-terminally to the insert, geneticin resistance  
 mCherry-C1  vector containing mCherry, geneticin resistance  
 
2.1.5 Cell Lines and Bacterial Strains 
 BHK21 Baby hamster kidney fibroblast cell line  
 BHK21-C13 Clone 13 of the BHK21 cells  
 C2C12                                                Murine myoblast cell line (C2), as generated by 
Yaffe and Saxel (1977); clone 12 established by 
Blau et al. (1983) 
 C2C12 +hDes C2C12 cells transfected with particular human 
desmin constructs 
 RD     Human rhabdomyosarcoma cell line  
TG1     Highly competent strain of E. coli  
Vim-/-     Embryonic fibroblasts originating from  
vimentin-/- mice 
 
2.1.6 Cell Culture Media and Solutions   
Bovine Serum Biochrom  
Fetal Calf Serum (FCS)  Biochrom 
LB-Medium (Lennox)  Sigma-Aldrich  
LB     20g/l LB-Medium, 10mM MgSO4 *7 H2O, 
pH7.5 
L-glutamine (200mM stock)  Invitrogen   
Non-Essential Amino acids  Biochrom 
Goat Serum    Invitrogen 
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DMEM    Dulbecco’s Modified Eagle’s Medium (Gibco) 
MEM Minimum Essential Medium (Biochrom)  
Growth medium (GM) DMEM, supplemented with 2mM L-glutamine 
and 10% fetal calf serum  
Differentiation medium (DM) DMEM, supplemented with 2mM L-glutamine 
and 2% Horse serum 
MEM Medium   MEM, supplemented with 2mM L-glutamine, 1%  
Non-essential amino acids and 10% FCS  
EDTA/PBS    0.02% EDTA in 1x PBS  
Trypsin    0.25% / 0.05% Trypsin (Invitrogen) 
 
2.1.7 Buffer Solutions 
 SDS running buffer (10x):   0.25M Tris, 1.92M Gylcine, 1% SDS, pH 8.3  
Stacking gel buffer (4x):  0.5M Tris, 0.4% SDS, pH 6.8 
Separating gel buffer (4x):  1.5M Tris, 0.4% SDS, pH 8.8 
Borate buffer (20x):    0.4M Boric acid, 20mM EDTA, pH set to 8.8  
Phosphate buffered saline, PBS (10x):   143 mM NaCl, 26.8 mM KCl,  
64.6 mM Na2HpO4 x 2 H2O, 14.7 mM KH2PO4; pH 7.4 (autoclaved)  
Tris buffered saline with Tween, TBST (10x):  100 mM Tris pH 8.0, 1.5 M NaCl, 
0.5% Tween 20     
 
2.1.8 Reagents and enzymes  
Lipofectamine LTX      Life Technologies 
ECL solutions       Western Lighting  
BIX-01294       Sigma 
 Geneticin (G418)      PAA 
 Fluoromount-G (with DAPI)     Southern Biotech 
 Dynabeads M-270 Epoxy     Invitrogen 
Pefablock       Serva 
T4 ligase        Serva 
Bovine serum albumin (BSA)    New England BioLabs 
Benzonase nuclease       Novagen 
EcoRI, BamHI, SalI, BspEI, XhoI     Roche 
Mini-, Midiprep kits, Gel extarction kit   Qiagen 
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QuikChange XL Site-Directed mutagenesis kit  Stratagene 
2.1.9 Laboratory Equipment and Software 
 Axioskop 40 Microscope with AxioCam MRc   Zeiss 
Blotting apparatus        Cti 
Cell counter (Vi Cell-XR)      Beckman 
CH350 12-bit camera       Photometrics  
Olympus IX70  microscope, DeltaVision microscope system  Applied Precision 
Petri dishes (10 cm, 6 cm diameters)     Falcon 
Pipetboy        Integra 
Polyvinyl difluoride (PVDF) membrane     Immobilon-FL 
SDS PAGE apparatus      BioRad 
Shaker         Stuart Scientific 
SoftWorks imaging software      Softworks Inc. 
Spectrophotometer        Jenway  
Table top centrifuge        Eppendorf 
X-ray films         Fujifilm 
 
2.2 Methods 
 
2.2.1 Maintenance of Cell Cultures   
All cell lines (except BHK21-C13) were cultured in 10 cm x 2 cm Petri dishes with 10 ml 
growth medium (GM). In case of 6 cm Petri dishes, half of the volumes indicated below were 
used. The cells were incubated at 37 oC (5% CO2) and passaged every 3 days. In case of 
C2C12 cell lines, cells were always split when they were underconfluent (about 80% 
confluence). After two days, additional 30% of culturing medium was added to the cells. To 
passage the cells, the medium was removed and the cells were washed briefly in 5 ml 0.05% 
EDTA/PBS and rinsed with 3 ml 0.25% Trypsin. After 1-2min at room temperature (RT), the 
cells were resuspended in 5 ml GM and split accordingly. In case of C2C12 cells, they were 
split 1:20 and 1:30, whereas in case of RD cells, they were split 1:10 and 1:12. In case of 
C2C12 cells transfected with hDes constructs, they were split 1:10 and 1:15 and maintained in 
additional 1.5 mg/ml genaticin (G418). BHK21-C13 and RD cells were cultured in the MEM 
medium and split 1:10 and 1:15 or 1:8 and 1:12, respectively, every three days.  
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In case of C2C12 cell differentiation, the cells were cultured up to over 95% confluence. GM 
was then removed and the same volume of differentiation medium (DM) was added. If BIX-
01294 (2.5 mg/ml stock solution) was added, it was diluted 1:1000 in the DM. If geneticin 
(G418) was added, it was done as above (1.5 mg/ml). After three days additional 20% of DM 
(with a corresponding amount of either BIX-01294 or G418) was added to the cells. The cells 
were used for further experiments after 6 days in DM. 
 
2.2.2 Cloning and Mutagenesis 
hDes gene sequence was subcloned from p163/7 vector into a pBluescript II KS+ using EcoRI 
enzyme. To clone into the pJ6Ω vector, the sequence was digested with BamHI (1 h 
digestion) and SalI (10 min partial digestion) restriction enzymes. After digestions, the 
products were run on a low melting agarose gel (0.5% LE and 0.5% GTG agarose) after 
which the corresponding bands were cut out and purified from the gel according to the manual 
(Qiagen). 
 
In case of cloning hDesWT into pIRES_mCherry vector, hDesWT was first amplified by 
polymerase chain reaction (PCR), using Desmin01_for/_rev primers. Subsequently, both the 
PCR-amplified hDesWT DNA and the pIRES_mCherry-LaminA were digested with BspEI 
and XhoI enzymes and ligated together. 
 
The restriction digestions and ligations with T4 ligase of plasmid and an insert were all 
performed according to the instruction manuals (Roche Diagnostics). The ligation reaction 
was then added to 50 μl of TG1 competent E. coli cells, which were then incubated 20 min on 
ice, 2 min heat-shocked at 37 oC, cooled down 3min on ice following addition of up to 1ml of 
LB medium and incubation for 1 h at 37 oC. The bacterial cells were plated (either 1:10 ratio 
or they were spun down at 4000 g for 5 min and the pellet was resuspended in 200 μl of LB).  
 
Minipreps of the bacterial cultures were performed according to the company instructions 
(Qiagen). To verify the digestion products, the minipreps were subjected to restriction 
digestions with the respective enzymes (as above). Site directed mutagenesis (using the 
QuikChange XL Site-Directed mutagenesis kit) was performed on the hDes gene subcloned in 
pBlueScript II KS+ vector and subsequently transformated into the TG1 E. coli (procedure as 
above). For each of the mutations (hDesE245D, hDesR350P) a corresponding set of forward 
(for) and reverse (rev) primers was used (section 2.1.3). After clone verification by restriction 
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digestion and sequencing (done by GATC Biotech) the mutant sequences were subsequently 
recloned into the pJ6Ω vector and again verified by restriction digestion and sequencing. 
Finally, a larger amount of plasmid DNA was generated by using a midiprep procedure 
(Qiagen). 
 
2.2.3 Cell Transfection 
C2C12 (as well as Vim-/- fibroblasts) cells were transfected using Lipofectamine LTX 
according to the manufacturer’s instructions (Invitrogen), using the Plus reagent. Cell 
transfections were always performed at 50% confluence on 2cm Petri dishes in DMEM only, 
with an additional medium change to GM 6h after transfection. In case of stable cell lines, 
geneticin (G418) was added to the medium (to 1.5 mg/ml final concentration) the following 
day. The cells were left in the dish with occasional (2-3 days) partial (20-50%) medium 
removal and replacement with the fresh medium. Only once the dish was starting to get 
confluent were the cells trypsinised and split and always cultured in the medium with G418.  
 
In case of transfections of C2C12 cells with hDesR350P cloned into vector p163/7, the vector 
was cotransfected with the mCherry-C1 vector, which contains the geneticin resistance gene 
(in ratio 9:1). This was necessary for generating a cell line stably expressing the mutant 
desmin as the vector p163/7 does not contain any resistance genes.  
 
2.2.4 In situ Cell Fractionation: Preparation of Cytoskeletons 
The cells were grown in 10 cm x 2 cm Petri dishes until confluence. In case of differentiation, 
the procedure was performed after 6 days in DM. The cell dish was first rinsed twice with a 
solution of 1x PBS (with 25 μm Pefablock and 1 μg/ml PMSF) at RT. 1 ml of digitonin buffer 
(Dig, 0.5x PBS, 50 mM MOPS pH 7.4, 10 mM MgCl2, 50mg/ml digitonin, 1 mM EGTA with 
0.5 mM Pefablock, 0.5 μg PMSF) was then added and the cells were incubated for 1 min on 
ice. The buffer was collected in an Eppendorf tube and the cells were subsequently incubated 
with 1 ml Low NP40 buffer (LIB, 0.5x PBS, 50 mM MOPS pH 7.4, 10 mM MgCl2, 0.2% 
NP40, 1 mM EGTA with 0.5 mM Pefablock, 0.5 μg PMSF) for 4 min (on ice). The LIB 
sample was then collected in another Eppendorf tube and then 1 ml of High NP40 buffer 
(HIB, 0.5x PBS, 50 mM MOPS pH 7.4, 10 mM MgCl2 and 1.0% NP40 with 0.5 mM 
Pefablock, 0.5 μg PMSF and 250 U Benzonase nuclease) was added (incubation on ice). After 
5min, 200 μl of pre-cooled 5 M NaCl was added to the buffer and the cells incubated for 
another 3 min (with occasional rinsing). Finally the cell remnants were collected by scraping 
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in 1.2 ml buffer and the sample was stored in a fresh Eppendorf tube. After 10 min 
centrifugation (at 13000 rpm, 4 oC) 800 μl of supernatant was collected in a separate tube and 
the rest of supernatant discarded. The pellet was resuspended in 200 μl of UBS (6.7 M Urea in 
1x Laemmli sample buffer) and heated at 95 oC for 3min.  
 
For determination of the protein content in LIB the Bradford protein assay was used according 
to the standard procedure. In short, the Bradford stock reagent was diluted 1: 5 in water. For 
the blank measurement, 1 ml of the dilution reagent was used. In case of the BSA standard 
curve, 1, 2, 3, 4, 5 μl each of 1.05 mg/ml bovine serum albumin (BSA) stock solution was 
dissolved in 1 ml Bradford dilution. For each measurement, 1 μl of the LIB samples was 
mixed in 1 ml of Bradford dilution. Three separate dilutions were prepared for each 
measurement. After 5 min of incubation, the light intensity (at 595 nm wave length) was 
measured. The concentration of the protein was calculated from the standard BSA curve.  
 
2.2.5 SDS-Polyacrylamide Gel Electrophoresis and Western Blotting 
All the SDS polyacrylamide gel electrophoresis (PAGE) were performed on 8% separating 
gels in SDS running buffer (2.6% stacking gels). Samples were mixed with 3x SDS sample 
buffer (190 mM Tris HCl pH 6.8, 30% glycerol, 6% SDS) and immediately heated at 95 oC 
for 5 min. The SDS PAGE was run at 80 V for 15 min and another 75 min at 120 V 
(maximum amperage).  
 
To perform protein transfer to a PVDF membrane (0.45 μm pore size), the membranes were 
briefly activated in 100% ethanol and rinsed in the Borate buffer. Subsequently, they were 
placed on the gels and covered with three layers of Whatman filter paper (and two thin 
sponges on either side). The cassette was then placed into the blotting chamber so that the 
membrane faced the positive electrode and blotted for total of 110 min (starting from 100 mA 
with a 100 mA increase every 5 min to reach 500 mA, at maximum voltage). Protein transfer 
would be verified by Ponceau staining (for 5 min) and subsequent destaining with ddH2O and 
1x TBST.  
 
To subject the membrane to the antibody reactions it was first blocked in 5% milk (m/v) in 1x 
TBST (blocking solution) for 1 h at RT (or overnight at 4 oC). The antibody was then diluted 
(table in section 2.1.2) in the blocking solution and added to the membrane (incubated for 1 h 
at RT), following washing in 1x TBST 3 times for 5 min. Secondary antibody (from Jackson 
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ImmunoResearch, Horse radish peroxidise, HRP-conjugated) was then diluted 1: 5000 (in the 
blocking solution) and incubated with the membrane for 30 min at RT, on a shaker, followed 
by washing in 1x TBST, 2 times for 15 min, once for 30 min. Before incubating with the X-
ray films, each membrane was incubated (10 s) with the mix of ECL solutions (1 ml each per 
9 cm x 6 cm of membrane). 
 
2.2.6 Cell Fixation and Immuno-cytochemistry (ICC) 
Cells were initially grown on cover slips (in case of C2C12 differentiation, the cells were 
differentiated on chrome-sulphuric acid (H2SO4 / CrO3-activated cover slips to prevent cell 
detachment). In all cases, cover slips with 1.5 mm thickness were used. Prior to ICC, the 
cover slips were rinsed in 1x PBS with 2 mM MgCl2 and then incubated for 5 min in 
methanol, following washing in acetone for 30 s and air drying.  
 
In the first part of the ICC procedure, the cells were briefly washed in ICC washing solution 
(0.002% Triton X100 in 1x PBS) and blocked with blocking solution (1: 10 goat serum 
diluted in 1x PBS) for 20 min in a humid chamber. In case of ICC with the HD350P and 
HD2, the cover slip was dipped 3 times into 2M urea following 5 min washing in the ICC 
washing solution prior the blocking step. Subsequently, the antibodies were diluted in the 
same blocking solution (20 μl per cover slip, diluted as in the table in section 2.1.2) and added 
onto the cover slips (1 h incubation, RT). If another primary antibody was used, it was added 
following the first incubation the same way after removing the previous antibody dilution by 
slanting the cover slip.  
 
Subsequently, the cover slips were washed in the ICC washing solution (2 times 5 min) and 
incubated with the secondary antibody (from Jackson ImmunoResearch, either Alexa488  or 
568 or Cy3-conjugated), previously diluted 1: 100 in 1x PBS, for 30 min. If more secondary 
antibodies were used they were added consecutively after removing the previous secondary 
antibody dilution exactly as above. After washing off the secondary antibody, 2 incubations in 
the ICC washing solution for 5 min each, the cells were briefly rinsed in ddH2O followed by a 
brief rinse with 100% ethanol and then left to air dry. Finally the cover slips were mounted by 
putting them on top of a 3μl drop of Fluoromount-G (with DAPI) on a glass slide and left 3 h 
or overnight before using them for microscopy.  
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2.2.7 Hematoxylin-Eosin (HE) Staining 
The cells were grown on square (18 x 18 mm) cover slips, fixed in methanol/acetone (as 
above) and washed in in ddH2O. In the subsequent staining procedure the cover slips were 
placed on a porcelain holder and incubated in Hemalum (8 min) following its washing in a 
running tap (with calcium) water. Subsequently the cover slips were stained in 1% Eosin for 5 
min and shortly rinsed with ddH2O. Then the cover slips were briefly washed in 70%, 96% 
and then 100% ethanol and incubated with Xylol for 2 min. The cover slips were then 
mounted using the Eukitt mounting medium. The HE staining was kindly performed by 
Michaela Hergt (our group).  
 
2.2.8 Microscopy and Image Processing 
All the images were made using the Deltavision system using the SoftWoRx software. All the 
images were acquired in 50 stacks with 0.2 μm distance (1024x1024 image size, 100x 
magnification) and with the exposure times set for the maximum in the focus. Deconvolution 
was always performed using the Enhanced Additive algorithm with 10 cycles. The images 
were finally saved in JPEG format. 
 
In the case of staining cytoskeleton with MF20 and HD1, as well as with images from HE 
staining, the images were made with the Axioskop microscope at 40x or 63x maginification. 
For MF20 and HD1 statistics, between 250 and 350 MF20-possitive cells were counted in two 
separate experiments. In case of C2C12 +hDesE245D DM +G418 and +bix cells, three 
different experiments were performed. The total number of cells being 3- to 5-fold higher.  
 
2.2.9 Immunoprecipitation (IP) 
The cells were first grown in a 10 cm dish (up to a confluence of over 80%). The cells were 
then trypsinised (as described in 2.2.1) and collected in 5 ml medium of which 0.5 ml were 
used for cell counting (Beckman cell counter). The cells were then centrifuged (1000 rpm, 2 
min) and the medium was removed. The cells were then incubated with 1ml of RIPA buffer 
(0.1% SDS, 1% NP40, 150 mM NaCl, 50 mM Tris pH 8.0) for 5min. Subsequently the cells 
were transferred into an Eppendorf tube and centrifuged at 13000 rpm for 10 min at 4 oC.  
 
Prior to antibody coupling to the Dynabeads M-270 Epoxy (Invitrogen), the antibody was 
dialysed against PBS (2 times 30 min). Antibody coupling was performed according to the 
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product manual. IP was performed according to the Dynabeads Protein G manual 
(Invitrogen). For sample incubation, the volume of the cells RIPA lysates corresponding to 
0.5 million cells (volume set to 250 µl) was incubated for 20 min on a rotator and it was 
finally eluted in 25 μl 0.1M glycine, pH 2.3. The beads were finally heated in 20 μl 1x 
Laemmli sample buffer (70 oC, 10min). For Western blotting half of the collected IP sample 
was loaded onto an 8% polyacrylamide gel.  
 
2.2.10 Electron Microscopy (EM)  
Conventional Epon-embedding-ultrathin sectioning-EM was performed by the division for 
electron microscopy in DKFZ (head: Dr. Karsten Richter). In short, the cells were fixed in 2% 
formaldehyde and then 2% glutaraldehyde, following the washing in 2 mM MgCl2 and 66 
mM CaCo-buffer pH 7.2, for 1 h at 4 °C. The samples were washed 5 times in 66 mM CaCo 
66-buffer and treated with 1% OsO4 in 40 mM CaCo-buffer for 60 min. Subsequently, the 
samples were washed in 66 mM CaCo twice and then 3 times with ddH2O. After subsequent 
washing in 33% and 50% ethanol, the procedure was continued with a 70 min incubation in 
Uac1%/ 70% ethanol. The samples were then washed in 70%, 95%, 100% ethanol at RT, 1 h 
total, and then incubated with Epon without accelerator (2A plus 2B) in 10% ethanol at RT 
overnight. After inverting the gelatin-capsules onto the cell layer, it was left to polymerase at 
60 °C overnight.  
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3. Results 
3.1 Generating desmin antibodies and the analyses of their specificity 
 
In the first step of the indicated analyses, different antibodies were generated and tested with 
respect to their specificity in both WB and ICC. The analyses were performed on C2C12 
(mouse) and RD (human) cells, in case of the ICC. For WB, mouse and human desmin 
(m/hDes) recombinant proteins and extracts from C2C12 or RD cells were used. The antibody 
used for a standard comparison was a mouse monoclonal D9 antibody. Initially the location 
the epitope of the antibody was narrowed down and the antibody was analysed with respect to 
the extent of its specificity for either m/hDes. This was performed by applying different 
dilutions of the antibody on WB membranes containing varied amounts of the two proteins 
(ranging from 1 to 100 ng). Thereby the specificity of the antibody was reliably determined. 
 
3.1.1 Anti-desmin D9 monoclonal antibody detects mouse and human desmin with equal 
specificity  
In order to narrow down the epitope of the mouse monoclonal antibody (monoAb) D9, 
recombinant peptides of different fragments of mDes were run on the gel and blotted onto a 
membrane. The recombinant peptides included the full length desmin (positive control), 
desmin 1st half (peptide of amino acids 1-240) and desmin 2nd half (amino acids 251-470). In 
addition, headless desmin (ΔHead) and two tailless desmin (ΔTail) fragments were also used 
in the procedure. 500 ng and 100 ng of each protein was loaded (figure 7). As it can be seen 
from the blot, the antibody detected only the desminΔhead and desmin(251-470) but not any 
of the desminΔtail constructs nor desmin(1-240). Therefore, the WB clearly demonstrated that 
the epitope of the D9 antibody is located on the tail domain. The tail domain of desmin 
contains 61 amino acids (figure 6A) out of which only one amino acid is different between 
mouse and human desmin sequences (appendix 2).  
 
In the subsequent steps, varied amounts of m/hDes (1/5/10/20/50/100 ng of each) were loaded 
on the gel and blotted on the PVDF membrane. By applying different D9 dilutions on the 
blots (1: 2000 / 1: 5000 / 1: 10 000) one could have compared the specificity of the antibody 
at different concentrations on different amounts of desmin (figure 8). The experiment has 
demonstrated that with dilution of 1: 2000 one could detect up to 5 ng of either h/mDes 
equally (with traces of 1ng of protein being detected) after 2 min of film exposure to the 
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membrane. In case of 1: 5000 and 1: 10 000 dilutions, one could detect up to 5 or 10 ng of 
protein respectively. In all dilutions, the relative amounts of signals of detected in the lanes of 
either mouse or human desmin were mostly quite similar. This result demonstrates that D9 is 
equally specific for both mouse and human desmin proteins.  
 
 
Figure 7. Narrowing down the epitope of D9 antibody. WB on 500 ng / 100 ng of different 
Des constructs: mDes complete (WT), desmin 1st half (amino acids 1-240), desmin 2nd half 
(amino acids 251-470), headless (ΔHead) and two tailless (ΔTail1/2) desmin truncations.  
 
 
 
 
Figure 8. Specificity of D9 antibody on m/hDes. Different amounts mouse (m) and human 
(h) desmin were blotted on the membranes and detected with the D9 antibody diluted (A) 1: 
2000, (B) 1: 5000 and (C) 1: 10 000. 
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3.1.2 Human desmin 1 antibody is highly specific for human desmin  
In order to generate an hDes specific antibody, we have chosen a 10-amino acid epitope 
sequence located on the non-α-helical head domain of the hDes, which differs at two amino 
acids positions from mouse desmin (figure 9). The corresponding peptide was initially 
injected into two guinea pigs, two mice and two rats. Immunisation of mice and rats was done 
for the purpose of attempting to generate monoclonal antibodies. However, despite the fact 
that one of the sera from the rats did contain antibodies which could specifically detect hDes 
(data not shown), no hDes-specific monoclonal antibodies could have been found in the 
subsequent screening. In addition, both guinea pigs generated antibodies that also had a high 
extent of crossreactivity with mDes and which stained poorly in ICC (data not shown). 
 
 
Figure 9. Epitopes of the HD1 and MD1/2 antibodies. Sequence alignment of the first 100 
amino acids of human and mouse desmin proteins (colour code: amino acids with a 
substitution were coloured with yellow or red background; the same amino acids in the two 
sequences were coloured with grey background; the amino acid lacking in mDes has green 
background). The epitopes of the antibodies are marked: blue for HD1 and red for either MD1 
or MD2 antibodies. 
 
In the subsequent steps we have injected the same peptide into two rabbits and again tested 
the sera. Not only that the blood sera of the two rabbits contained antibodies highly specific 
for hDes but they also had a very high titre (figure 10A). Subsequently the sera were tested by 
ICC on the two desmin-positive cell lines, mouse C2C12 and human RD. Both sera were 
negative on murine C2C12 cells but the serum from the first rabbit (human desmin 1, HD1) 
stained the desmin filaments very strong (figure 10B).  
 
Subsequently, the HD1 antibody was purified from the serum and the eluate with the antibody 
was collected in the fractions 3 to 6 (all antibody purifications were done by PSL GmbH, 
Heidelberg). As the antibody generated was polyclonal all of the fractions were tested for the 
antibody specificity. Namely, as the serum contained all of the antibodies generated by the 
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immune system of the animal upon injections, the fractions collected after antibody elution 
could have contained antibodies of different specificities or binding affinities. Nevertheless, 
all of the HD1 fractions have detected up to 5 ng of hDes at dilutions up to 1: 20 000 
(fractions 5 and 6) or 1: 10 000 in fractions 3 and 4 (figure 11). Interestingly, although HD1, 
fraction 6 had lower antibody concentration (0.3 mg/ml) than either fraction 4 or fraction 5, 
the same or higher dilution of fraction 6 than either of these two antibodies fractions detected 
up to 1 ng of hDes (compared to 5 ng in case of these two antibody fractions). This 
observation does indicate heterogeneity of the antibody fractions with respect to the 
antibodies they contain.  
 
 
Figure 10. Testing of the sera from rabbits immunised with hDes-specific peptide. (A) 
WB with recombinant mouse (m) and human (h) desmin (100 ng of either per lane) tested 
with rabbit 1/2 sera (Rab 1/2) diluted 1: 1000, 1: 2000 and 1: 5000. (B) ICC on RD cells with 
rabbit 1 serum (1: 100 diluted). Blue, desmin; scale bar, 20 μm. 
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Figure 11. Specificity of different fractions (3 to 6) of the eluted HD1. Different amounts 
of mouse (m) and human (h) desmin were blotted on the membranes and detected with the 
HD1 antibody diluted (A) 1: 10 000 (fraction 3, 0.2 mg/ml of antibody), (B) 1: 10 000 
(fraction 4, 0.5 mg/ml conc.), (C) 1: 20 000 (fraction 5, 0.4 mg/ml conc.) and (D) 1: 20 000 
(fraction 6, 0.3 mg/ml conc.), as well as D9 (1: 2000) WB on 100 ng h/mDes.  
 
3.1.3 Whereas mouse desmin 1 antibody detects both mouse and human desmin proteins, 
mouse desmin 2 antibody is specific for mouse desmin on WB 
In the subsequent steps we have attempted to generate a mDes-specific antibody. The purpose 
for that was to generate an antibody that could be used for ICC in addition to HD1 to examine 
the extent of segregation of the transfected and endogenous desmin proteins. Although one 
would expect that D9 antibody, which detects both mouse and human desmin equally (figure 
8), could be used in addition to HD1 the arguments in favour of generating the mDes-specific 
antibody would further be addressed in sections 3.1.5 and 3.3. Thereby, two other epitopes 
were chosen (8 and 13 amino acids) for the mDes antibodies generation (figure 9), for which 
peptides were synthesized and injected into two rabbits each. Similarly as for HD1, the 
antibodies were purified from 10ml blood serum from the animals (one for each of the 
animals injected with the same peptide, with higher specificity and titre of the antibodies) and 
collected in fractions 3 to 6 (named mouse desmin 1 and 2, MD1 and 2).  
 
The antibodies generating by immunising rabbits with the two peptides vary with respect to 
their specificity. Namely, whereas MD1 detects both mouse and human desmins (albeit mDes 
with a higher specificity, figure 12A1–5), MD2 appears to be mDes-specific but with 
significantly lower binding affinity (i.e., very low dilution of the antibodies are needed for the 
protein detection on WB). However, although MD1 detected filaments thoroughly in ICC 
(figure 13) MD2 appears to stain only sections or points of filaments (data not shown).  
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Figure 12. Specificity of different fractions (3 to 6) of the eluted MD1 and MD2 
antibodies.  (A) Different amounts of mouse (m) and human (h) desmin were blotted on the 
membranes and detected with the MD1 antibody (A1) fraction3, (A2) fraction 4, (A3) fraction 
5, (A4) fraction 6 (antibody dilutions are indicated above each blot), as well as (A5) D9 (1: 
2000). (B) Different amounts of mouse (m) and human (h) desmin were detected with MD1, 
fraction3 (B1) 1: 50 000 and (B2) 1: 100 000, as well as MD2 antibody (B3) fraction3, (B4) 
fraction 4, (B5) fraction5 and (B6) fraction6, all 1: 500 diluted.  
 
Finally, as the fraction 3 of MD1 still appeared to detect mDes with significantly higher 
specificity than hDes, we have attempted different strategies to obtain an antibody highly 
specific for mDes. In the ICC we have washed the antibody with high (up to 2 M) 
concentrations of NaCl with a rationale that more stringent washing could remove antibodies 
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weakly bound to the hDes epitopes. The procedure was, however, unsuccessful as the 
antibody affinity to mDes appeared not to be sufficiently higher as compared to its binding 
affinity to the hDes. In the second step, we have generated a peptide of the corresponding 
hDes epitope aiming to use it to bind a subset of antibodies from the eluate more specific for 
hDes. The rationale was that there was a possibility, due to the high mDes-specificity of the 
MD1, fraction3, that there could be a significant proportion of antibodies in the eluate specific 
for mDes only. However, as in the previous case, we were unsuccessful in purifying an 
antibody detecting predominantly mDes (data not shown). Namely, there was very little 
antibody bound to the purification column whereas the unbound antibody was equally specific 
for desmin in C2C12 (mouse) and RD (human) cells. 
 
3.1.4 Successful generation of antibodies specific for either DesWT or DesR350P 
In the final step of generating antibodies to specifically detect mutant or endogenous WT 
desmin rabbits were immunised with 9-amino acid peptides from the desmin coil 2B region, 
surrounding the arginine (R) 350. Hence two rabbits were immunised with the WT version of 
the peptide and two with hDesR350P mutant peptide. The first sera analyses indicated that, 
whereas both antibody sera specific for the hDesR350P-epitope detected the mutant protein 
specifically on the WB, only one of the antibodies generated against the DesWT epitope 
specifically detected the protein (figure 14).  
 
 
Figure 13. ICC with MD1/2 on C2C12 cells. (A) The MD1 antibody serum (green), diluted 
1:50, stained filaments thoroughly (B) as did the D9 antibody (red). (C) Merge; blue, DAPI; 
scale bars, 20 μm. 
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Figure 14. Testing of the rabbit sera detected against DesR350 epitope. 100 ng of 
hDesWT and hDesR350P was detected with 1: 200, 1: 500 and 1: 1000 dilutions of (A) anti-
DesWT (1), (B) anti-DesWT (2), (C) anti-DesR350P (3) and (A) anti-DesR350P (4). Note 
that anti-DesWT (1) antibody specifically reacts with DesR350P. 
 
Therefore sera 2 of the DesWT (human desmin 2, HD2), as well as the hDesR350P (human 
desmin hDesR350P, HD350P)-immunised rabbits, were used for the standard antibody 
purification procedure to obtain 4 fractions of each of the antibodies. Fraction 4 of each of the 
antibodies was then tested in higher dilutions on the WB with respect to their specificity to the 
hDesWT and hDesR350P proteins (figure 15). Whereas HD350P was found to detect 10 ng 
hDesR350P at 1: 20 000 dilution, HD2 detected the same amount of hDesWT at 1: 10 000. 
 
 
Figure 15. Specificity testing of the HD2 and HD350P. Different amounts of hDesWT (R) 
and hDesR350P (P) were detected on the WB with (A) D9, (B) HD2 fraction 4: (B1) 1: 5000 
and (B) 1: 10 000 and (C) HD350P fraction 4: (C1) 1: 5000, (C2) 1: 10 000 and (C3) 1: 20 
000. Note that in figure (A) hDesR350P runs somewhat higher than the hDesWT.  
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Figure 16. ICC of C2C12 +hDesR350P with HD350P. After treatment with 2 M urea, the 
cells expressing the hDesR350P desmin mutant were detected using the HD350P antibody 
(fraction4, 1: 100). The (B) HD350P (green) signals were found to largely colocalise with (A) 
D9 (red), which can detect both endogenous and transfected desmin proteins. (C) Merge. 
Blue, DAPI; scale bars, 20 μm.  
  
The initial ICC procedure previously used for D9, HD1 and other desmin detection, was 
unsuccessful using these purified antibodies. Therefore, in order to make the epitope more 
accessible (discussed in section 4.1.1) the cover slips were briefly treated with 2 M urea (the 
procedure as described in the methods section, 2.2.6). Although only few cells were 
successfully stained by this method the staining on the cells positive with the HD350P was 
similar to that of the HD1 (figure 16). Further (i.e., longer) treatment of cells with 2 M urea 
did not significantly improve the staining efficiency with HD350P but appeared to affect the 
overall cell architecture (data not shown).  
 
3.1.5 Antibodies binding to different epitopes of IF proteins could have a different staining 
pattern in ICC  
As generation of mDes-specific antibody that would be suitable for use in the ICC was 
unsuccessful we analysed the potential of the available antibodies to be implemented in the 
study. One of the possibilities would be to use the D9 antibody which recognises both h/mDes 
(figure 8). The obstacle of using this antibody in the current studies is further addressed in 
section 3.3.1. As it has been previously indicated, desmin and vimentin were previously found 
to form heterodimers (Quinlan and Franke 1982) in hamster kidney cells. Therefore we 
employed a clone of the same cell line, BHK21-C13 to investigate the possibility for specific 
detection of the endogenous (in this case, vimentin/desmin) IF network in parallel with the 
transfected desmin. Thereby, we have proceeded with staining the cells with D9, made in 
mouse, and VimCT, a rabbit antibody. 
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Figure 17. ICC of BHK21-C13 with C-terminal vimentin and desmin antibodies. Two 
examples of cells stained with D9 desmin antibody, red (A1, B1) and VimCT vimentin 
antibody, green (A2, B2). (A3, B3) Merge. Blue, DAPI; scale bars, 20 μm. 
 
As it can be seen on figure 17 the two IF systems, vimentin (figure 17A,B2) and desmin 
(17A,B1), both stained with antibodies generated against epitopes on their tail domains, 
colocalise to a significant extent (17A,B3). However, what one repeatedly notices is that, 
whereas the vimentin antibodies appeared to spread rather uniformly throughout the cytosol 
desmin IFs appeared to form bundles. Such bundles appeared to have been more specifically 
and thereby disproportionally stained by the D9 antibody and were most commonly located in 
the perinuclear region (such as in image 17A).  
 
To resolve if such disproportional staining of the desmin and vimentin antibody could reflect 
the different distribution of the desmin or vimentin IFs, the staining was repeated on the 
BHK21 cells with two antibodies binding to different epitopes on vimentin (figure 18). 
Whereas the epitope of VimCT antibody is located at the tail domain of vimentin the epitope 
of the Vim3B4 mouse antibody is located at the coil 2 in the rod domain of the protein. It can 
be seen in figure 18a that the Vim3B4 signals colocalised with the VimCT ones to a very high 
degree. However, there were some filaments stained only or predominantly with the VimCT 
antibody. Do note in figure 18a1 that there is a significant area in the periphery of the cell that 
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is only weakly stained with the Vim3B4 antibody. However, another frequent observation, 
depicted by example on figure 18B, was that there was a significant portion of single 
filaments stained with only one of the antibodies (either VimCT or Vim3B4). Hence in 
interpretation of the ICC on IFs one should also take into consideration the epitopes of the 
particular antibodies.  
 
 
Figure 18. ICC of BHK21 with VimCT and Vim3B4 antibodies. Two examples of cells 
stained with Vim3B4, red (A1, B1) and VimCT, green (A2, B2), both vimentin antibodies. 
(A3, B3) Merge. The arrows in (B) point to the filaments stained either with Vim3B4 (grey) 
or VimCT (yellow arrow). Blue, DAPI; scale bars, 20 μm. 
 
3.2 Analyses of the IF proteins in C2C12 cells 
 
Before performing any analyses on the C2C12 cells transfected with either WT or mutant 
desmin proteins, the cell line was first characterised with respect to the key IF proteins 
studied, namely the nuclear A-type lamins as well as desmin and vimentin. All of the analyses 
were performed both in cells grown in GM as well as those incubated in the DM for 6 days. 
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3.2.1 A-type lamins are differently distributed in C2C12 cultured in growth or 
differentiation medium 
Distribution of A-type lamins was compared in the C2C12 (GM) and (DM) cells. As it was 
briefly indicated in the introduction, distribution of A-type lamins was found to differ in cells 
in GM and of those cultured in DM (Muralikrishna et al. 2001). As these observations were 
made in ICC we wanted to examine if the same conclusion could be drawn from A-type 
lamins distribution in different fractions upon cell fractionation. Therefore, the cells were first 
treated with a buffer containing digitonin (Dig fraction), which principally permeablises the 
plasma membrane; subsequently, the cells were treated with low concentration of NP40 
detergent and salt (LIB fraction), following the harsh treatment with higher concentration of 
NP40 and NaCl and subsequent centrifugation (yielding supernatant and pellet fractions). 
Using this procedure, we could separate the cytosolic (i.e., mitotic) lamins (Dig), from soluble 
(LIB) and filament-incorporated lamins, probably as single, shorter filaments (Sup. fraction) 
or longer filaments and filament networks (Pel. fraction).  
 
As it can be seen in figure 19, C2C12 (DM) had a higher amount of A-type lamins (detected 
with LaZ antibody) most of which was found in the pellet fraction (i.e., insoluble). In contrast 
to that, A-type lamins in C2C12 (GM) were found in both supernatant and the LIB. This 
result indicates that, similarly to the previous observations by ICC, A-type lamins are also 
found in nucleoplasm (i.e., part of them remained soluble) in the undifferentiated cells, in 
contrast to C2C12 (DM) where almost all of A-type lamins were lamina-incorporated.  
 
 
Figure 19. WB with an A-type lamin antibody (LaZ) on fractions of C2C12 (GM) and 
(DM) cells. Different fractions of C2C12 (GM) and (DM) cells: Dig, LIB, Sup and Pel 
(diluted 1:2), as described above. Loading scaled to 10 μg of protein in LIB fractions. 
 
In a further step, A-type lamins distribution in the C2C12 (GM) and (DM) was compared to 
that in RD cells. This has been performed as an additional control of the system as RD cells 
would have been expected to have a similar A-type lamins distribution as C2C12 (GM). 
Although A-type lamins content in RD cells was appeared to be lower than in C2C12 cells 
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(figure 20A) their fraction distribution was similar to that of C2C12 (GM). Note that the 
exposure of the film to the membrane was prolonged to attempt to detect the weak signals in 
the LIB and Sup fractions of the C2C12 (DM). Therefore, the amount of lamins in C2C12 
(GM) and (DM) pellet fractions appeared similar. Furthermore, WB was also performed with 
an antibody against Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH), a common 
positive control for extraction of the cell cytoplasm (figure 20B). Such control was necessary 
to confirm that the A-type lamins extracted in the LIB fraction do represent the nucleoplasmic 
lamins and not the mitotic ones. As GAPDH was extracted first in the digitonin fraction, the 
extraction of the soluble cytosolic material was concluded to be successful. Note that GAPDH 
is extracted also in the other fractions indicating the protein might not be found entirely free 
in the cell cytosol. Therefore the A-type lamins extracted in the LIB fraction did indeed 
appear to represent the nucleoplasmic and not cytosolic (i.e., mitotic) ones.  
 
 
Figure 20. WB with LaZ on fracions of RD, C2C12 (GM) and (DM) cells. Different 
fractions of RD, C2C12 (GM) and (DM) cells: Dig, LIB, Sup and Pel (diluted 1:2), as 
described above. Loading scaled to the equal amounts of protein in each of the LIB fractions. 
The blots were stained with antibodies against (A) LaminA/C and (B) GAPDH.  
 
3.2.2 Desmin expression increases in C2C12 cells upon differentiation 
The C2C12 fractions (both GM and DM) were also used on a WB with a D9 antibody. The 
purpose was to examine the distribution of desmin in the fractionation procedure before and 
after the cells have been induced to differentiate. As it can be seen in figure 21, the amount of 
desmin was several fold higher in C2C12 (DM) compared to the (GM) cells. Note also that 
only a very small amount of desmin was extracted in the Sup fraction of the C2C12 (DM) 
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cells. After overexposure of the film to the membrane traces of signals were also detected in 
the C2C12 (GM) Sup lane (data not shown). 
 
 
Figure 21. Des expression in C2C12 (GM) and (DM) cells. WB with D9 desmin antibody 
on the fractions: Dig, LIB, Sup and Pel (diluted 1:2) of the C2C12 (GM) and (DM) cells. 
Loading scaled to 10 μg of protein in LIB fractions.  
 
In the subsequent steps we have performed ICC on these cells (both GM and DM) using the 
same (D9) antibody. As it can be seen on figure 22, the amount of desmin filament networks 
in C2C12 (DM) cells appeared significantly higher (the filament network was more dense) 
compared to the cells in GM. Furthermore, there was a significant number of multinucleated 
myotubes (figure 22B) after the cells were grown for 6 days in DM. However, no 
multinucleated cells containing more than 6 to 8 nuclei have been observed.  
 
 
Figure 22. ICC with desmin antibody on differentiating C2C12 cells. C2C12 (A) (GM) 
and (B) (DM) cells stained with a desmin (D9) antibody (green). Blue, DAPI; scale bars, 20 
μm. 
 
In order to attempt to further optimise the differentiation procedure and to enhance the cell 
fusion during differentiation the standard protocol was somewhat optimised. Namely, 
previously the cells were always allowed to get over 95% confluent before changing the 
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medium to DM. The optimisation of the procedure included growth of cells to over 95% 
confluence and their subsequent splitting 1:5 using the 0.05% trypsin. The use of lower 
concentration of trypsin allowed for the cells to detach from the bottom of the dish with most 
of them still attached to several neighbouring cells. Hence the cells were split upon the 
initiation of the fusion which could further enhance their fusion potential.  
 
 
Figure 23. ICC on C2C12 (DM) cells. (A, B) The cells were detached with 0.05% trypsin (1 
to 2 days) prior to differentiation induction. Red, desmin (D9); blue, DAPI; scale bars: 20 μm. 
 
The examples of multinucleated myotubes generated by the above described procedure are 
shown in figure 23. Thereby, the application of the procedure for cell fusion enhancement 
appeared to have been quite successful, whereby it led to generation of cells consisting out of 
more than 50 nuclei. However, even though the cells were grown on chrome-sulphuric acid-
activated cover slips, or different methods to maintain their attachment to the cover slips were 
used, they have predominantly detached from the cover slips. The images that were made 
were of the myotubes located on the edges of the cover slips. Therefore, as the sufficient 
generation of multinucleated myotubes on cover slips by this method was obstructed by the 
large amount of cells detaching from the glass surface this procedure was not used any 
further. 
 
3.2.3 Whereas undifferentiated C2C12 cells are basophilic, they become eosinophilic upon 
differentiation 
In the subsequent analyses of the C2C12 (GM) and (DM) cells, they were subjected to 
hematoxylin-eosin (HE) staining. This staining method is widely used in histological analyses 
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to differentiate some particular basophilic (hemalum-stained, blue or purple) and eosinophilic, 
commonly basic parts of the cell such as cytoplasm (pink or orange structures). The procedure 
was done on both C2C12 (GM) and (DM) cells and it was kindly performed by Michaela 
Hergt (our group). 
 
 
Figure 24. Hematoxylin-eosin staining of C2C12 cells. Whereas C2C12 (GM) cells are only 
(A) or predominantly (B) basophilic, the (DM) cells are largely (C) or exclusively (D) 
eosinophilic. Scale bar, 20 μm.  
 
As depicted in figure 24A and B, the C2C12 (GM) cells were predominantly stained by 
hemalum. This result indicates that the undifferentiated C2C12 cells have largely basophilic 
cytosol. On the other hand, C2C12 (DM) cells were largely eosinophilic, which is a common 
feature of protein rich structures both in cytosol and extracellular space (figure 24C and D). 
Thereby, the HE staining results indicate that the cell differentiation in case of C2C12 cells is 
also accompanied by a change of the chemical composition of the cytoplasm.  
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3.2.4 Electron Microscopy of C2C12 (GM) and (DM) cells revealed distinct patterns of their 
IFs 
In the last step of analyses on the C2C12 cells cultured in GM versus DM desmin networks 
were observed under the electron microscope (EM) using the conventional Epon-embedding-
ultrathin sectioning-EM procedure for the sample preparation (figure 25). The imbedding as 
well as sample imaging was kindly performed by the team of the Core facility of electron 
microscopy in the DKFZ, headed by Dr. Karsten Richter. The aim of the procedure was to 
reflect on the observations in the ICC performed and compare them with the imaging on 
higher resolution.  
 
As it can be seen on figure 25A1 and A2, the IFs in the C2C12 (GM) appeared uniformly 
distributed throughout the cytosol. Detection of the thin layer of the nuclear lamina was 
somewhat hindered by the dense chromatin material located at the edges of the INM. In case 
of C2C12 (DM) cells (figure 25, B1 and B2), the cytosolic IFs appeared more densely 
distributed throughout the cytoplasm. Furthermore, they also appeared more elongated and 
predominantly aligned in parallel. In some cases, dense bundles of IFs were found adjacent to 
the plasma membrane (figure 25B1). In case of cell protrusions (figure 25B2), they were more 
densely packed in filament bundles lining the plasma membrane. Such cellular protrusions 
were also commonly observed in the ICC as the very narrow pointed extensions of the cells 
which were stained strongly with the desmin antibodies (such as in figures 22b and 23b). 
 
3.3 Effects of transfection of human desmin in C2C12 myoblasts 
 
In the subsequent set of experiments, different hDes constructs, i.e., the hDesWT, 
hDesE245D and hDesR350P mutants cloned into pHβAPr-1-neo vector were used for cDNA-
transfection of C2C12 cells. The vector contains a geniticin (G418) residence gene thereby 
allowing transfected cells to be selected for. The minimal concentration of G418 necessary for 
selection was determined to be 1.5 mg/ml. Therefore, in the subsequent experiments cells 
were always incubated in the GM containing G418 in order to maintain a culture of cells 
stably expressing the hDes constructs.  
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Figure 25. C2C12 cells under EM. (A1, A2) C2C12 (GM) cells prepared with conventional 
Epon-embedding-ultrathin sectioning and imaged on the EM; scale bars: 1000 nm. Images 
(B1, B2) are found on the following page. 
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Figure 25. C2C12 cells under EM (continuation from the previous page). (B1, B2) C2C12 
(DM) cells prepared with conventional Epon-embedding-ultrathin sectioning and imaged on 
the EM; scale bar: 1000 nm. 
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3.3.1 hDesWT is readily incorporated into the pre-existing mouse desmin filament network  
In the first step of the analyses of the effects of the transfected proteins an ICC with both HD1 
and D9 antibodies was performed on C2C12 cells expressing hDesWT (C2C12 +hDesWT). If 
not otherwise explicitly noted, HD1 staining was always done prior to incubation of cells with 
the D9 antibody. In figure 26, an example of a cell stained thoroughly with both D9 and HD1 
antibodies is shown, demonstrating that hDesWT is expressed and integrated into the 
endogenous filaments. hDesWT expression and integration persisted for more than 20 
passages after the initial transfection (data not shown). Although there has been some 
heterogeneity in the cell population with respect to the amount of hDesWT being expressed, a 
large majority (over 70%) of cells expressed the protein to a significantly high extent (i.e., 
HD1 staining reflected the D9 staining to a significant extent).  
 
 
Figure 26. C2C12 +hDesWT cell stained with HD1 and D9. Two examples (A and B) of 
C2C12 +hDesWT cells stained with both (A1, B1) D9, red and (A2, B2) HD1 green. (A3, B3) 
Merge. Blue, DAPI; scale bars, 20 μm.  
 
However, HD1 signals did not always appear to fully colocalise with D9 ones. Namely, as D9 
antibody detects both human and mouse desmin whereas HD1 detected only human desmin, 
one would expect the HD1 signals to fully colocalise with the D9 ones. As it can be seen in 
figure 26B3, a significant amount of HD1 (green) signals was not fully colocalised with the 
D9 (red) ones. The same type of observation was also made when the cells were initially 
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incubated with the D9 antibody and subsequently stained with the HD1 (data not shown). In 
consideration of this effect one should also take into an account that the epitopes of the two 
antibodies, HD1 and D9, are located in head and tail domains, respectively. Such difference in 
the position of the epitope could affect the geometry of the antibody binding to the protein 
(the problem is further discussed in section 4.1.2).  
 
 
Figure 27. C2C12 +hDesWT cells images taken at different Z-height. Images of two cells 
(A, B) were taken at different Z-heights (200 nm distance) of the image stack. (A1, B1) An 
arrow points at the green (i.e., HD1-stained) filament; (A2, B2) the arrow points at the 
apparently corresponding red filament (i.e., D9-stained). Blue, DAPI; scale bar, 20 μm.  
 
In the subsequent steps the images obtained by wide field microscopy in a stack of slides were 
analysed by comparing neighbouring images in a stack. Namely, in figure 27 two examples 
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were given (A and B, two images of each) with the apparently same filaments stained 
predominantly with HD1 (green signals, arrows in A1 and B1) or D9 (red signals, arrows in 
A2 and B2). One should also point out that, though the D9 epitope is located in the tail 
domain (figure 7), and the HD1 epitope is located in the head domain (figure 9). The problem 
is further discussed in more detail in section 4.1.2.  
 
3.3.2 hDesE245D is largely integrated into the endogenous desmin filaments 
In the following experiments, the same type of analyses was performed on C2C12 
+hDesE245D cells. As it can be seen on figure 28A (1-3), hDesE245D was predominantly 
integrated into the endogenous filaments. The rate of transfection and expression of 
hDesE245D was similar to that of the hDesWT (over 70%). Nevertheless, unlike the 
hDesWT, in several instances, predominantly in hDesE245D-trainsiently transfected C2C12 
cells one could see a very bright, diffuse desmin staining (both with HD1 and D9, figure 28B 
1-3). Such result indicates that, although the previous in vitro and in vivo studies have found 
DesE245D to have no effects on the filament formation in SW13 cells (Bär et al., 2005b) it 
might still negatively affect the desmin IF network on a rare occasion in special cell systems. 
 
In addition to the analyses of the effects of the mutant desmin on the endogenous desmin IF 
network, the vimentin IF system in C2C12 +hDesE245D cells was also analysed by ICC. As 
it can be seen in figure 28C (1-3), endogenous vimentin (stained with Vim3B4 antibody) 
colocalised well with the transfected (i.e., HD1-stained) hDesE245D protein. The staining and 
colocalisation pattern of HD1 and Vim3B4 in these cells resembled that of HD1 and D9. 
Thereby, one could finally conclude that the effects in C2C12 cells stably expressing 
hDesE245D largely reflect those in vimentin- and desmin-free SW13 cells.  
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Figure 28. C2C12 +hDesE245D cells stained with HD1, Vim3B4 and D9 antibodies. 
hDesE245D-transfected cells stained with HD1 (green, A2, B2 and C2) and D9 (red, A1 and 
B1) or Vim3B4 (red, C1). (A3–C3) Merge. Blue, DAPI; scale bars, 20 μm.  
 
3.3.3 hDesR350P is asymmetrically distributed in C2C12 cells  
The second desmin mutation analysed, i.e., R350P, had a much more complex phenotype in 
cells transfected with the constructs containing this desmin mutation. Namely, the 
observations made in various cells varied significantly with respect to the amount of the 
protein expressed or its distribution among small groups of cells or large populations. 
Therefore, as no rigorous complete statistical analysis could be made (which is discussed at 
greater length in section 4.2.2), I do outline this observation by presenting some examples of 
cells encountered under these conditions.  
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In the initial experiments with hDesR350P-transfected cells, the p163/7 vector was used. As 
the vector contained no resistance gene against any selection marker, it was cotransfected 
with a plasmid containing geniticin resistance (described in section 2.2.3). Already in the 
initial experiments, a large heterogeneity with respect to the amount of hDesR350P that the 
cells expressed was observed. A large majority contained weak, diffuse traces of HD1 
staining throughout the cytosol (figure 29A) or local accumulations of the HD1 signals (figure 
29b). Considering the previously described phenotype of the mutant in SW13 cells (Bär et al. 
2005a), one could have expected such a result. However, a fraction of cells contained HD1-
stained filaments (i.e., hDesR350P) which fully or largely colocalised with the endogenous 
desmin filaments (figure 29C). As a matter of fact, in a few rare cases, as shown on figure 
29C, the HD1-stained filaments were almost indistinguishable from those in hDesWT-
transfected cells. Namely, the structure and pattern of those filaments in some cases 
resembled that of HD1 staining in C2C12 cells transfected with the hDesWT construct 
(compare with figure 26).  
 
The same observations was made with C2C12 cells stably expressing hDesR350P (cloned in 
the pHβAPr-1-neo vector, figure 30). However, in this case we frequently observed HD1-
possitive cells with a completely collapsed desmin IF network, mainly around the cell nucleus 
(figure 30A). Another frequent observation was that pairs of neighbouring cells, one 
expressed distinctly different amounts of hDesR350P than the other. In some cases, the cell 
expressing a higher amount of hDesR350P (B2, HD1-stained) seemed to have a similar or 
even higher amount of total desmin (figure 30B1, D9-stained). Both of the cells that contained 
higher and lower amounts of hDesR350P had a punctuated HD1 (but also to some extent D9) 
staining patterns. However, in some cases the hDesR350P appeared to have been largely 
integrated into the endogenous IFs of one of the cells (figure 30C) whereas the other one 
contained a predominantly weak, punctuated HD1-staining pattern. Interestingly, as shown in 
figure 30c, the cell containing higher amounts of (apparently IF-incorporated) hDesR350P 
also had a lower amount of total (i.e., D9-stained) desmin. 
 
Results 
 
46 
 
 
Figure 29. C2C12 +hDesR350P (p163/7) cells stained with HD1 and D9. Three examples 
of cells which have (A) which contained large amounts of diffuse hDesR350P throughout the 
cytosol, (B) cells where hDesR350P is largely accumulated in one part of the cell, or (C) cells 
with hDesR350P appeared to be integrated into their endogenous desmin filaments. (A1-C1): 
red, D9; (A2-C2): green, HD1; (A3-C3): merge; blue, DAPI; scale bars, 20 μm.  
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Figure 30. C2C12 +hDesR350P cells stained with HD1 and D9. Examples of cells with (A) 
an apparent collapse of the desmin IF network around the nucleus and somewhat (B) 
asymmetrical distribution of hDesR350P in close neighbouring cells. In some cases (C) the 
asymmetry in hDesR350P between neighbouring cells was far more apparent (A1-C1): red, 
D9; (A2-C2): green, HD1; (A3-C3): merge; blue, DAPI; scale bars, 20 μm. 
 
In the subsequent analyses, the vimentin network has been looked at in C2C12 +hDes 
hDesR350P cells (figure 31). Similarly to the previous observations one could find pairs of 
cells with distinctly different hDesR350P expression (figure 31A, from the cells transfected 
using the p163/7 vector). In this particular case, vimentin distribution was also found to be 
different in cells expressing different amounts of hDesR350P. Once the analyses were 
repeated on cells stably expressing hDesR350P (transfected using the pHβAPr-1-neo vector) 
hDesR350P was found to be fully incorporated into the endogenous filaments (figure 31B), as 
well as asymmetrically distributed in pairs of neighbouring cells (in case of figure 31c where  
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Figure 31. C2C12 +hDesR350P cells stained with HD1 and Vim3B4. C2C12 cells 
transfected with hDesR350P, either cloned in (A) p163/7 or (B-D) pHβAPr-1-neo. Examples 
of cells with asymmetric (A and C) or a similar (D) distribution of hDesR350P. Example (B) 
depicts a cell with a very efficiently integrated hDesR350P into the endogenous IF network. 
(A1-D1): red, desmin (D9); (A2-D2): green, HD1; (A3-D3): merge; blue, DAPI; scale bars, 
20 μm.  
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in one of the cells there was a complete collapse of the vimentin IFs). Finally, on a rare 
occasion pairs of neighbouring cells with a quite similar distribution of hDesR350P, as well as 
vimentin (figure 31D) were also observed. 
 
Although the observation of asymmetrical distribution of hDesR350P in neighbouring cells 
was so far indicated only in the cases of pairs of neighbouring cells, such observation was also 
somewhat frequent in groups of cells. Namely, in cases when multiple cells were observed in 
a group there was also a high extent of heterogeneity with respect to the distribution of 
hDesR350P. For example, in some cases of groups (4 or more) of cells only one of them 
which contained some hDesR350P incorporated into the endogenous filaments was found 
(figure 32A and B). In some other cases, however, there were two cells per group which had 
such a phenotype (figure 32C). However, in several instances one could have also seen that 
several cells in a group had hDesR350P integrated into the desmin IFs (figure 32D).  
 
In all the experiments discussed so far the double immunostaining ICC was performed by 
incubation with HD1 antibody following the same procedure with D9 or Vim3B4 antibodies. 
Therefore, to address the issue of possible epitope hindrance of one antibody by the other 
(discussed in section 4.1.1), the experiment was repeated on hDesR350P-transfected C2C12 
cells by antibody incubation in a different order. This was done as in several instances 
previously the cells which had a stronger HD1-staining (such as in figure 30c or, to some 
extent, 30b) had a lower amount of D9 staining. However, once the ICCs in different order 
were performed, no significant effect of the antibody staining patterns with respect to the 
order that the incubations were performed was observed. In some cases, cells that had HD1-
stained filaments (figure 33A), also had a stronger D9 staining compared to those around 
them which had no HD1-stained filaments, even though it was done after the incubation with 
the HD1 antibody. Therefore, in cases where D9 antibody incubation was done first, no clear 
epitope competition was observed as both antibodies appeared to stain the transfected and the 
endogenous desmin thoroughly (figure 33b and c). 
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Figure 32. Groups of C2C12 +hDesR350P cells stained with HD1 and D9. Groups of 
C2C12 +hDesR350P cells: (A, B) examples of single cells with HD1-stained filaments in a 
group of 4 or 5 cells; (C) an example of two cells in a group with hDesR350P integrated into 
the endogenous filaments; (D) several cells in a group positive for filamentous HD1 staining. 
(A1-D1): red, D9; (A2-D2): green, HD1; (A3-D3): merge; blue, DAPI; scale bars, 20 μm.  
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Figure 33. Images of C2C12 +hDesR350P cells stained with HD1 and D9 in a different 
order. Cells stained with a different order of antibody incubation. (A) HD1 incubation first, 
following D9 incubation; (B, C) First D9 and subsequently HD1 incubation was performed. 
(A1-C1): red, desmin (D9); (A2-C2): green, HD1; (A3-C3): merge; blue, DAPI; scale bars, 
20 μm. 
 
3.3.4 Western blotting of the cell extracts revealed that the amount of hDesR350P in C2C12 
transfected cells decreases during subsequent passages  
So far the analyses of the C2C12 cells transfected with either hDesWT or mutant desmin 
proteins have been discussed with respect to the observations in the ICC. Such approach 
allowed for analyses of individual cells with respect to the expression level of the transfected 
protein as well as topological issues. In case of hDesR350P transfected cells such analysis 
was shown to be important as it allowed the delineation of the variable phenotypes that 
different cells exhibited. However, this approach lacks conclusive quantitative information on 
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how the mutant protein is expressed. Thereby, WB of the cell fractions (as in section 3.2.1) of 
all three hDes-transfected cell lines was performed with respect to their total and transfected 
desmin content in different fractions.  
 
The results of the WB are shown in figure 34. In case of hDesWT- or hDesE245D-transfected 
cells, the amounts of both total (A) and transfected (B) desmin appeared similar between the 
two cell lines. C2C12 +hDesR350P cells, however, had somewhat lower amount of total 
desmin (a) and a significant amount of reduction in hDesR350P (figure 34B, compared to 
either hDesWT or hDesE245D). Such observation has been more pronounced with 
subsequent cell passaging, whereby by passage 10 or 12 the cells would contain only traces of 
hDesR350P (observations by microscopy, data not shown). Furthermore, this progressive 
reduction in the amount of hDesR350P expressed in these cells was also reflected in the WB 
whereby in higher passages (passage 8 after transfection) one could detect only traces of 
hDesR350P extracted in these cells (further described in section 3.4.1). Both hDesWT and 
hDesE245D on the other hand were stably expressed to a similar extent even after passage 10 
as determed by WB (figure 34B). 
 
 
Figure 34. WB on C2C12 +hDesWT, hDesE245D and hDesR350P cell lines fractions 
with D9 and HD1. The total amount of desmin (A), as well as the amounts of transfected 
desmin (B) were analysed in fractions (Dig, LIB, Sup, Pel 1:2) of different C2C12 +hDes cell 
lines. Loading was scaled to 10 μg of protein in LIB of each sample.  
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3.3.5 mCherry-tagged hDesR350P is degraded by the C2C12 cells 
In order to attempt to follow up on the observation of asymmetrical distribution of 
hDesR350P in different cells in vivo, we have cloned the gene into a vector with an mCherry 
located upstream (N-terminally) from the desmin insert site. Initially hDesWT has been 
cloned in the vector to analyse the effects of the mCherry tag on the IF protein itself. The 
initial observation (figure 35A) was that the mCherry-hDesWT gets fully integrated into the 
endogenous desmin filaments. However, a few cells contained what appeared to be small 
aggregates of the transfected mCherry-tagged desmin (figure 35B). After the subsequent cell 
passaging the amount of cells containing such desmin accumulations was increasing whereby 
10 passages after transfection almost all cells would contain predominantly such mCherry 
accumulations (data not shown).  
 
 
Figure 35. C2C12 +mCherry-hDesWT cells stained with D9. (A) mCherry-hDesWT is 
fully integrated into the endogenous desmin IFs; (B) an example of a cell where, even though 
the mCherry-hDesWT is predominantly integrated into the endogenous desmin filaments, an 
accumulation of it at one site could have been observed. (A1, B1): red, mCherry-hDesWT; 
(A2, B2): green, D9; (A3, B3): merge; blue, DAPI; scale bars, 20 μm. 
 
In a next step, we generated an mCherry-tagged hDesR350P plasmid in order transfect cells 
for live cell imaging. In each transfection experiment, some cells were found to express the 
mCherry-tagged hDesR350P, which appeared to be integrated into the endogenous filaments. 
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However, in all cases the cells either did not divide or most probably degraded the mCherry-
tagged desminR350P as the signal was lost after several hours of live cell imaging (data not 
shown). In order to try to determine what is causing the problem, cells stably expressing 
mCherry-hDesR350P were collected and fractionated. As it can be seen on the WB of their 
pellet fractions (figure 36), the mCherry-hDesWT appears to be degraded whereby only one 
band in blot stained with an mCherry antibody is detected. The band also corresponds to one 
band in either D9 or HD1 blots. In case of the mCherry-tagged hDesR350P, no signal was 
detected with the mCherry antibody and only one band, of approximate size of the DesR350P, 
was detected with D9 but not HD1 antibody. Note that the amount of the transfected, 
mCherry-tagged hDes (the top lane in all three blots) was considerably higher than the 
amount of the endogenous desmin (the smallest band located above the 56kDa band). 
 
 
Figure 36. WB on pellets of C2C12 +mCherry-hDesWT and hDesR350P. Loading: pellets 
of the C2C12 +mCherry-hDesWT (mC-WT) or +mCherry-hDesR350P (mCh-R), as well as 
recombinant desminR350P (R350P). Antibodies: D9, HD1, α-mCherry.  
 
3.3.6 Whereas hDesWT forms irregular filaments in Vim-/- fibroblasts, hDesR350P forms 
aggregates  
In addition to transfections of the hDesWT and desmin mutant genes into C2C12 cells, one 
additional transfection control has been performed. Namely, the observed results, especially 
concerning the integration of hDesR350P into endogenous IFs, did not correspond to some 
previous observations (Bär et al. 2005a). Thereby the transfections with hDesWT and 
hDesR350P were performed in a cell line fully devoid of any IF proteins, such as Vim-/-. 
These fibroblasts do not contain any desmin or vimentin IF proteins thereby being similar to 
the SW13 cells in which the previous experiments have been performed. However, in contrast 
to SW13 cells, which do not support the establishment of a well-spread desmin cytoskeleton, 
Vim-/- fibroblasts are suitable for generating an optimal desmin system (such as in Sharma et 
al. 2009). The test would have also demonstrated to what extent is the observed heterogeneity 
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of hDesR350P filament integration cell type- or vector- specific (previous experiments have 
been done using the p163/7 vector).  
 
As it can be seen on image 37A, hDesWT was able to form short filaments in the Vim-/- 
fibroblasts but they were highly irregular (compare with C2C12 cells, figure 26). Such result 
indicates that the endogenous IFs (constituted of either vimentin or desmin) might be crucial 
for formation of a proper IF network in a cell transfected with hDesWT. However, in case of 
hDesR350P, all of the HD1- and D9-possitive cells contained only aggregates of the signal as 
well as some punctuate structures in the background. No case of filament formation was 
observed thereby being in agreement with the previous in vitro data (Bär et al. 2005b) 
indicating that hDesR350P alone is not able to form IFs.  
 
 
Figure 37. Vim-/- fibroblasts transfected with (A) hDesWT and (B) and hDesR350P. The 
cells were stained with both D9, red (A1, B1) and HD1, green (A2, B2). (A3, B3) Merge; 
blue, DAPI; scale bars, 20 μm.  
 
3.3.7 mDesWT does not  co-immunoprecipitate with the hDes  
In the final stage of the analyses of the hDes-transfected C2C12 cell lines, hDes variants were 
immuneprecipitated (IPed) from the transfected cells and analysed if the endogenous mDes 
would have coimmunoprecipitated with the WT or mutant desmin protein. The cells have 
been fully lysed with a RIPA buffer and subsequently the IPs were analysed on WB with HD1 
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but also mouse desmin-specific antibody, MD2 (as described in section 2.2.9). The WB with 
HD1 antibody (figure 38A) has demonstrated that the IP of the hDes was successful in case of 
hDesWT and hDesE245D. Do note that, due to the very low amount of the hDes in case of 
these cells, the HD1 WB was performed with a higher concentration (1: 2000 dilution) of the 
antibody. However, no hDesR350P was detected in the corresponding IP sample. Whereas the 
amounts of the hDesWT and hDesE245D were similar in the RIPA samples the amount of 
hDesR350P was significantly lower. No protein was immunoprecipitated in case of the 
untransfected C2C12 cells (data not shown). 
 
However, the endogenous mDes was coimmunoprecipitated from either of the samples (figure 
38B) including the C2C12 +hDesWT cell extract. This result indicates that although m- and 
hDes do appear to form heteropolymers (figure 26) once the cells are extracted in RIPA buffer 
the two desmin-species are not found in the same structures.  
 
 
Figure 38. WB of the hDes IP in C2C12 +hDesWT, hDesE245D and hDesR350P cells. In 
all cases a sample of the input was loaded (RIPA) corresponding to 20 000 cells, the eluted 
sample (IP, 5-fold concentrated) as well as the unbound material (Sup, also corresponding to 
the volume of 20 000 cells). Recombinant Des (human and mouse, 20 ng each) were loaded in 
addition. The membranes with samples were stained with (A) HD1 (1: 2000) and (B) MD2 (1: 
200) antibodies.  
 
3.4 Differentiation of the human desmin transfected C2C12 cells 
 
3.4.1 The amount of transfected desminR350P reduces upon differentiation of C2C12 cells 
A major aim of the study was the analysis of the effects of the two mutants on myoblast 
differentiation. Therefore C2C12 cells were employed as they are an often used cell system 
Results 
 
57 
 
for investigation of muscle cells differentiation. As it has been previously shown (section 3.2), 
these cells could be successfully induced to differentiate by culturing them in a medium 
containing a low amount of serum (but without the selection maker in this case, which is 
further discussed in the section 4.3.1). However, there have been previous reports of some 
lamin A mutants responsible for one type of myofibrillar myopathy to inhibit C2C12 
differentiation (Favreau et al. 2004). Therefore, as there was a possibility that expression of 
the desmin mutants would delay differentiation in these cells, we have also done the 
experiments with BIX-01294 (bix) in DM in parallel. This compound is an inhibitor of G9a 
methyltransferase (Kubicek et al. 2007) which is an enzyme that has been previously shown 
to methylate MyoD and thereby prevents myoblast differentiation (Ling et al. 2012a). 
Thereby, in addition to the experiments with DM, C2C12 cells were also differentiated using 
BIX-01294 in addition to the DM (DM +bix). 
 
 
Figure 39. WB with D9 and HD1 on cell fractions of C2C12 +hDes variants (DM) in 
early passages. Cell fractions (Dig, LIB, Sup, Pel 1:2) of C2C12 cultured in DM only or with 
BIX-01294 of +hDes (A) WT passage 4; (B) hDesE245D passage 3; and (C) hDesR350P 
passage 3. Loading: 8 μg of protein per LIB. 
 
In the first experiments with three cell lines C2C12 +hDesWT, E245D and R350P the cells 
were differentiated (in DM only, DM (-), or +bix) several passages after transfection they 
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were subjected to the fractionation procedure. The samples obtained were then loaded on gels 
and used for a WB with D9 and HD1 antibodies (figure 39). In case of hDesWT-transfected 
cells (figure 39A), the amounts of both total (D9) and hDesWT (HD1) desmin were higher in 
DM (-) than in DM (+bix) samples. Note that under the same incubation time with the film 
the HD1 signals were more intense than the D9 ones. In case of hDesE245D, the total amount 
of desmin (D9) was higher in (+bix) than DM (-) samples (figure 39B), whereas the amount 
of the transfected protein (HD1 blot) was again higher in (+bix) compared to the DM (-) cells. 
The same analysis was made for the C2C12 +hDesR350P cells (figure 39C). The most 
interesting observation was that the amount of transfected desmin was distinctly lower in case 
of these cells, as compared to either of the two other cell lines. Nevertheless, the total amount 
of desmin in +hDesR350P cells appeared the same or higher as compared to the case with the 
other cell lines (+hDesWT and hDesE245D, respectively).  
 
 
Figure 40. WB with D9 and HD1 on cell fractions of C2C12 +hDes (GM, DM) cells in 
later passages. Cell fractions (Dig, LIB, Sup, Pel 1:2) of C2C12 cultured in GM, DM (-) or 
with G418 of +hDes (A) WT, (B) hDesE245D and (C) hDesR350P. Loading: 10 μg of protein 
per LIB. 
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To determine if these effects persist in subsequent passages the cells were again differentiated 
and fractionated after passage 10. However, the cells in this case were also differentiated with 
G418 selection marker in DM in order to attempt to prevent the apparent loss of hDesR350P 
from the cells during the differentiation procedure. The WBs were again performed with the 
fractions of cells cultured in DM only or with G418, as well as in a standard GM (figure 40). 
The total amount of desmin in C2C12 +hDesWT cells has drastically increased upon 
differentiation but it was lower in DM (+G418) than in cells incubated in DM only (figure 
40A). Interestingly, this was also the case with hDesWT (HD1 blot). In case of +hDesE245D 
cells, the total amount of desmin as well as the amount of the transfected protein was similar 
between GM and DM cells and significantly higher in DM (+G418) cells (figure 40B). 
Finally, the amount of hDesR350P was lower in all three cases (GM, DM only or with G418). 
The total amount of desmin (D9) was higher in DM (-) than in GM cells and the highest in 
DM (+G418) cells (figure 40c). 
 
3.4.2 C2C12 cells expressing desmin mutants largely fail to fuse  
The WB data so far reflected the distribution of the total amount of desmin protein in the 
whole population of cells per dish. Although such analysis does aid in our understanding of 
the distribution of total and the mutant desmin proteins it falls short in clarifying the actual 
state of the filaments in different cells in a population. In order not to overstate the outcome of 
these analyses they needed to be correlated to the observations on individual cells. Thereby, in 
the follow-up experiments the cells were analysed by ICC by staining the differentiated cells 
with HD1 and D9.  
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Figure 41. C2C12 +hDesWT (DM) stained with HD1 and D9. The cells differentiated with 
(A) BIX-01294 or (B) G418. The cells were stained with both D9, red (A1, B1) and HD1, 
green (A2, B2). (A3, B3) Merge; blue, DAPI; scale bars, 20 μm. 
 
Some examples of C2C12 +hDesWT (DM) are given in the figure 41. When cells are 
differentiated in DM only or DM with BIX-01294 (figure 41A) the cells undergoing fusion 
still predominantly retained the hDesWT. Similarly, if the cells were differentiated in 
presence of G418 (figure 41B) most of the multinucleated cells still expressed the hDesWT.  
 
Once C2C12 +hDesE245D cells were induced to differentiate the situation was somewhat 
different. Both cell lines differentiated with G418 or in DM alone (figure 42a) had apparently 
similar amount of multinucleated cells in which hDesE245D was integrated into filaments. 
For +hDesE245D cells differentiated in the presence of BIX-01294 (figure 42B), the number 
of fused cells that were positive for HD1-stained filaments appeared lower. 
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Figure 42. C2C12 +hDesE245D (DM) stained with HD1 and D9. The cells were incubated 
(A) in DM only or (B) with BIX-01294. The cells were stained with both D9, red (A1, B1) 
and HD1, green (A2, B2). (A3, B3) Merge; blue, DAPI; scale bars, 20 μm. 
 
Finally, the same type of analyses was performed on C2C12 +hDesR350P cells (figure 43). In 
case of cells cultured in DM alone (figure 43A), no multinucleated cell with hDesR350P 
expression was observed. The same was the case for cells differentiated in the presence of the 
BIX-01294 inhibitor (figure 43B), where the majority of the cells, which was HD1-possitive, 
was unfused. The situation was the same in the case of the cells differentiated in the presence 
of G418 (figure 43C). Although in most experiments with hDesR350P-transfected cells some 
fused or even multinucleated cells were observed they were almost all negative for any IF-like 
HD1 staining. An example on figure 43B further describes a common observation in any of 
these cells: whereas there were still some cells, which appeared to contain hDesR350P 
integrated into filaments, they were predominantly myoblasts-like (single nucleated, round). 
On the other hand, the multinucleated cells, which did contain some hDesR350P, had only 
scattered, punctuated HD1-staining (figure 43B). 
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Figure 43. C2C12 +hDesR350P (DM) stained with HD1 and D9. The cells were incubated 
(A) in DM only, (B) DM with BIX-01294 or (C) with G418. The cells were stained with both 
D9, red (A1, B1, C1) and HD1, green (A2, B2, C2). (A3, B3, C3) Merge; blue, DAPI; scale 
bars, 20 μm. 
 
3.4.3 Distribution of A-type lamins in C2C12 cells transfected with desminR350P remains 
myoblast-like after induction of differentiation  
The analyses so far have indicated that either the expression of hDesR350P is significantly 
reduced upon the initiation of differentiation in the transfected C2C12 cells or that the mutant 
protein is being degraded. That was not the case with either hDesWT or hDesE245D-
expressing cells indicating that this particular mutant might be somewhat toxic to the cells. 
Therefore what remained open was the mechanism that the cells use to reduce the amount of 
this particular mutant. For instance, the cells could be rapidly degrading the mutant protein. 
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Another alternative would involve increasing the rate of proliferation whereby only a subset 
of the offspring cells could be accumulating the mutant protein. Such hypothesis was drawn 
from the apparently asymmetrical hDesR350P distribution in neighbouring cells (section 
3.3.3, depicted on figures 29 to 33). Considering the observation that the mutant protein was 
still present in the cells, but was largely excluded from the multinucleated ones, we have 
further analysed the cell cycle state of the cells transfected with the different hDes variants.  
 
 
Figure 44. WB of LaminA/C (LaZ antibody) on fractions of C2C12 +hDes (GM, DM) 
cells. Cell fractions (Dig, LIB, Sup, Pel 1:2) of cells cultured in GM or DM of C2C12 +hDes 
(A) WT, (B) hDesE245D and (C) hDesR350P. Loading scaled to the equal amounts of 
protein in each of the LIB fractions.  
 
As observed previously (figures 19 and 20A) A-type lamins distribution differs considerably 
between the undifferentiated and differentiating C2C12 cells. Namely, the undifferentiated 
myoblasts were shown to contain a considerable amount of A-type lamins in their soluble 
state, extractable in LIB and Sup fractions. Differentiated C2C12 cells, on the other hand, 
contained predominantly laminA/C extracted in the pellet fraction of the cell fractionation 
procedure. When this result was compared to the hDesWT and hDesE245D-transfected cells 
(figure 44A and B) it was observed that these cells also undergo differentiation successfully. 
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On the contrary, A-type lamins distribution in C2C12 +hDesR350P (DM) cells resembles that 
of the corresponding undifferentiated (GM) cells, indicating that a significant amount of those 
cells fails to enter the differentiation process. Yet one should also note that the amount of 
soluble, predominantly found in LIB but also in Sup fractions, laminsA/C in +hDesR350P 
(DM) cells is still lower than that in (GM) cells.  
 
3.4.4 C2C12 cells transfected with either of the mutant desmins express a higher amount of 
differentiation marker compared to those expressing wild type desmin 
Another way to analyse the differentiation of respective C2C12 cell lines was to compare the 
expression of myosin heavy chain (MHC) among them. MHC has been previously 
successfully used as a differentiation marker in C2C12 cells, as it is expressed already after 
three days of cell differentiation (for example, as used in the analyses reported in Ling et al. 
2012a). Therefore, we have initially cultured untransfected as well as hDesWT, hDesE245D 
and hDesR350P-transfected cells in DM only or with BIX-01294 and analysed their fractions 
with a MHC antibody, MF20 (figure 45).  
 
In all cases MHC was only detected in the Sup fractions. Interestingly, in case of both 
untransfected and hDesWT-transfected C2C12 cells the amount of MHC was lower in 
samples differentiated in the presence of BIX-01294. Furthermore, all hDes-transfected cell 
lines had a higher amount of MHC in their Sup fractions as compared to the untransfected 
cells. In contrast to what the A-type lamins distribution would suggest (figure 44C) the 
amount of MHC was the highest in hDesR350P cells. However, one should note once again 
that the fractionation distribution analyses reflect the sum of the protein amount in a cell 
population and thereby neglect any possible heterogeneity among the cells with respect to the 
distribution of a particular protein.  
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Figure 45. WB with MF20 on fractions of C2C12 +hDes (DM) cells. Cell fractions (Dig, 
LIB, Sup, Pel 1:2) of cells cultured in DM only or with BIX-01294 of (A) C2C12 cells, as 
well as +hDes (B) WT, (C) hDesE245D and (D) hDesR350P cells. Loading: 10 μg protein per 
LIB fraction.  
 
3.4.5 C2C12 cells expressing hDesR350P delay their differentiation  
In a final step to attempt to correlate the presence of a particular desmin variant in a cell with 
its success in differentiation the cells were stained with the MF20 and HD1 antibodies three 
days after initiation of differentiation. Although differentiating cells already express MHC at 
that stage very few of them have started fusing which allows for the analyses of individual 
cells with respect to their hDes content. Therefore, different cells lines (C2C12 +hDesWT, 
hDesE245D and hDesR350P) were induced to differentiate in DM only, or with either BIX-
01294 or G418 and the ICC with MF20 and HD1 was performed after 3 days of 
differentiation. In total, over 250 HD1-possitive cells of each sample were counted.  
 
As it can be seen on figure 46, C2C12 +hDesWT (DM with or without BIX-01294) and 
+hDesE245D (DM) cells have a similar percentage (between 66 to 73%) of MF20-possitive 
cells which also contained HD1-stained filaments. On the other hand, +hDesWT (DM +G418) 
cell line had a higher percentage (89%) of such cells, whereas hDesE245D (DM +bix) had a 
slightly lower portion (62%) of such cells. Interestingly, in case of +hDesE245D cells 
cultured in DM containing BIX-01294, the percentage of double-positive cells was 
significantly lower (43%). Note that the degree of variation was also higher in the last two 
cases. 
 
Finally, with respect to the C2C12 +hDesR350P MF20-possitive cells, which also contained 
HD1-stained filaments, the proportion of cells was significantly lower. Namely 10% of cells 
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cultured in DM and 5% of those cultured in DM +bix of all MF20-possitive cells contained 
HD1-stained filaments. Furthermore, only less than 1% (a single cell) of MF20-possitive 
C2C12 +hDesR350P cells cultured in DM +G418 contained HD1-stained filaments. 
Therefore, although the addition of G418 to DM had a positive effect in hDesWT-transfected 
cell line, the treatment did not help retaining the desmin mutant in the differentiating C2C12 
+hDesR350P cells.  
 
 
Figure 46. The percentage of MF20-possitive cells which contained HD1-stained 
filaments. The graph represents the percent of all MF20-possitive cells which also contained 
hDes filaments (HD1-stained) among C2C12 +hDesWT, hDesE245D and hDesR350P cells. 
The analyses were done after 3 days in DM only, with BIX-01294 or with G418.  
 
In addition, the same ICC was performed on the hDesWT, hDesE245D and hDesR350P cell 
lines six days after incubation in DM without or with BIX-01294. The observations made are 
largely in agreement with the above statistical analysis. In case of C2C12 +hDesE245D (DM 
+bix) cells, we observe a considerable number of cells, which contained HD1-positive 
filaments, that were not fused (figure 47A). In case of hDesR350P-transfected cells, almost no 
MF20- and HD1-double positive cell were found, i.e., MF20-positive cells were largely 
devoid of HD1-filaments staining (figure 47B). Thereby the outcome from analysis of MHC 
expression after six days of incubation with DM supported the conclusions made by statistical 
analyses of cells that were cultured for three days in DM. 
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Figure 47. C2C12 +hDes (DM +bix) stained with HD1 and MF20. C2C12 +hDes (A) 
hDesE245D and (B) hDesR350P cells incubated 6 days in DM +BIX-01294. The cells were 
stained with both MF20, red (A1, B1) and HD1, green (A2, B2). (A3, B3) Merge; blue, 
DAPI; scale bars, 20 μm. 
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4. Discussion 
4.1 The experimental system employed in the study 
 
4.1.1. Optimisation of the C2C12 growth and differentiation procedures  
With respect to the cell culture maintenance I would like to briefly reflect on some particular 
issues concerning culturing of the C2C12 cells. Namely, the procedure for C2C12 cells 
maintenance in the cell culture as well as differentiation outlined in the methods section 2.2.1 
was a result of various trial-and-error steps and thereby optimisations in the general cell 
maintenance and passaging procedures. C2C12 cell line was generated from the original C2 
muscle cells first isolated by Yaffe and Saxel (1977) by subcloning (Blau et al. 1983). Since 
then there has been a vast amount of published material about these cells demonstrating that 
they are used as a standard model system for studies on muscle cell biology. Therefore they 
appeared as the most suitable cell model for the study presented in this thesis.  
 
The first important point was concerning the optimal cell density for cell passaging. Namely, 
it is essential to note that these cells need to be passaged at somewhat lower (up to 80%) 
densities as it is crucial to prevent them from becoming too dense. The reason behind it is that 
once they reach higher densities they change their morphology to resemble the cells which 
have initiated differentiation. Once they are passaged after reaching such state they appear to 
grow faster than before. Under those conditions they could be eventually subcultured up to   
1: 800 whereby already after five days they would reach complete confluence. Due to these 
reasons the procedure was eventually standardised so the cells were subcultured 1: 20 and     
1: 30 every three days. The cells were always subcultured in two different dilutions as there 
appeared to have been some minor variations in the cell growth whereby at times they would 
have grown and gone through their cell cycle somewhat faster. Higher dilutions (than 1: 30) 
were also eventually avoided as the cells would then appear to grow in clusters. Thereby their 
local densities after several days of growth would have increased rapidly whereas there would 
have still been many areas in the dish where there were few or no cells.  
 
The procedure for cell differentiation was also further optimised. For example, cell 
differentiation was found to be the most effective (i.e., the largest number of fused, 
multinucleated cells have been observed) in dishes of 6 cm diameter. The reason for such 
more efficient differentiation in dishes of a smaller size could be an effect of different 
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alignment of cells due to the size of the dish or the different ratio of medium per area of the 
dish due to its different height. In addition, the height of the medium in the dish would also 
effect the O2 diffusion. As the amount of medium per area of a 10 cm dish was higher than in 
a 6 cm dish the availability of nutrients per cell was higher in the case the larger Petri dish. 
The main trigger for C2C12 differentiation is the serum starvation and therefore 
differentiation medium (DM) contains 2% horse serum whereas growth medium (GM) 
contains 10% FCS. In addition to the lower percentage of the horse serum used in DM it also 
has a lower amount of growth factors compared to the FCS as it is obtained from an adult 
animal.  
 
As C2C12 cells can be differentiated in a Petri dish they do indeed appear to be a powerful 
tool in muscle cell biology and hence have been implemented since the clone was first 
generated (Blau et al. 1983). As we wanted to examine the effects of the desmin mutants onto 
the myoblasts differentiation we have transfected the cells with the particular desmin 
constructs and followed the cells through differentiation. In order to specifically detect the 
transfected desmin mutants we also needed to generate antibodies which would specifically 
recognise it.  
 
4.1.2. Analyses of colocalisation of different antibodies 
During the in vivo analyses of the hDes-transfected C2C12 cells in ICC a problem arose due 
to the lack of complete colocalisation of antibodies binding to different epitopes on the same 
protein. Such problem was demonstrated in case with two different vimentin antibodies, 
Vim3B4 and VimCT (figure 18, section 3.1.5). The initial aim in this study was to generate a 
rabbit hDes-specific antibody (HD1 in this case) and use it in ICC on murine C2C12 cells 
together with an antibody which could recognise both m/hDes (i.e., D9). As the two desmin 
variants differ in very few amino acids (appendix 2), the approach appeared appropriate.  
 
Therefore, in the ICC with the two antibodies one would have expected a complete 
colocalisation of the HD1 antibody signals with those from D9. However, that was not always 
the case as indicated on the example in the figure 27 (section 3.3.1). Baring that in mind one 
could propose several possible reasons which could account for such discrepancy. One of the 
possible causes would be due to the effect of the masking of the antibody binding to the 
epitope. Namely, although the two epitopes are on the opposite sides (head and tail domains) 
of desmin the effects of blocking of their binding to the epitopes could occur due to their 
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association at the stage of ULF formation (section 1.1.5, figure 2). As the association of 
dimers at the stage of tetramer formation is antiparallel, the two epitopes would come closer 
to each other than one originally thought (Herrmann et al. 2009). Furthermore, as indicated in 
figure 27 the apparent lack of colocalisation was often observed in cases of filaments 
stretching over the nucleus. A similar point was demonstrated in the colocalisation study with 
vimentin antibodies which bind to the different epitopes on the protein, one in the tail domain, 
VimCT, and the other in the coil 2, Vim3B4 (figure 18, section 3.1.5). In this case, some 
filaments stretching over the cell nucleus were stained with only one of the two antibodies. 
Thereby one could hypothesize that the potential epitope availability and position of antibody 
binding could have further been affected by the IF geometry, i.e., its bending in this case.  
 
Therefore due to the colocalisation problem of the D9 and HD1 antibodies (depicted in figure 
27, section 3.3.1) we have attempted to generate the mDes-specific antibodies (MD1, MD2) 
using two different epitopes in the head domain as it was the case with HD1 (section 3.1.2, 
figure 9). The reason why two different epitopes were chosen, as compared to that of HD1, 
was due to their higher immunogenicity in case of mDes. Namely, the HD1 epitope in mDes 
contained one serine (S) less and had alanine (A) to threonine (T) substitution. Therefore, the 
peptide used for HD1 generation contained amino acids with two additional hydroxyl groups 
(as compared to the mDes epitope) making it more immunogenic. In addition, there would 
have been a clear obstacle in antibodies competing for the same epitope region if the same 
epitope would have been used for generating a mDes-specific antibody. 
 
Another clearly technical problem which could have affected the difference in the antibodies 
staining efficiencies was the fluorophore calibration. Namely, the fluorophore exposure times 
could not have been mutually calibrated as the strength of one fluorophore was not affected 
and could not have been linearly correlated to the other. In addition, the deconvolution 
process is automated and calculates the extent of the out-of-focus light of the two fluorophore 
channels independently. The similar problem, i.e., uncorrelated fluorophores light emission, 
also persisted with the confocal microscopy, which does not require deconvolution as the light 
beam is already focused. Therefore, the microscopy technical problems could not have caused 
the lack of complete colocalisation of signals (data not shown). 
 
Another alternative to the use of h/mDes-specific antibodies was addressed by attempting to 
use vimentin antibodies in addition. The two IF proteins are known to form heterodimers in 
Discussion 
 
71 
 
vitro (Wickert et al. 2005), which has also been found to occur in vivo in hamster kidney cells, 
BHK21 (Quinlan and Franke 1982). Thereby the cell line has been used to determine if 
antibodies binding to different epitopes on vimentin could be used to stain the endogenous 
desmin/vimentin network. The purpose of use of vimentin antibodies in ICC with the desmin 
mutant was to avoid the possible effects of epitope masking even in the case when the 
epitopes are located on distant parts of the protein.  
 
However, it has been demonstrated in the case of BHK21-C13 cells, which stem from a clone 
of the original cell line, that staining of the two networks in not fully identical (figure 17, 
section 3.1.5). Even more so, when two antibodies binding to different epitopes on vimentin 
were used there appeared to have been preferential binding of one or the other antibody to 
particular IF segments. In that respect, one could consider some cases where there some 
amino acid modifications, such as SUMOrylations of phosphorylations, which would have 
hindered the antibody binding to the particular epitope. The cases of partial epitope masking 
is not uncommon for ICC with antibodies against IF proteins. In particular, in analyses by 
Tunnah et al. (2005), epitopes of lamin B1 detected by some antibodies were masked in a 
subset of tissues. The same antibodies from the study were also successfully used for the 
protein detection in the WB. In case of desmin antibodies, as previously indicated and 
depicted in figure 18b (section 3.1.5), such cases were usually observed in areas above the 
cell nucleus. This particular example demonstrates that there were vimentin filaments stained 
with either Vim3B4 or VimCT antibodies whereas some IFs were stained with both of them. 
Such heterogeneity with respect to the staining patterns of the two antibodies would indicate 
that the epitope masking is an unlikely cause behind the different staining pattern of the 
individual vimentin IFs in this case.  
 
Finally, one could also address the need for generating an antibody specific for the transfected 
protein, as opposed to adding a peptide tag to a hDesWT or mutant desmin protein. Such 
approach would have allowed the analyses to be conducted in the conditions nearer to the 
native ones. Namely, the mCherry-tagged hDesR350P, as well as the hDesWT form of the 
tagged protein to a lower extent, is quickly degraded in the cells. In the WB it has been shown 
that there were both N- and C-terminal fractions of the mCherry-tagged desmin. This has been 
demonstrated by the WB of the pellets from the C2C12 cells transfected with the mCherry-
tagged desmin variants (figure 36, section 3.3.5). In particular, there are two additional lower 
molecular weight (Mw) bands below the full length desmin in the HD1 WB, compared to the 
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WB with D9. As the epitope of one of the antibodies, HD1, is located on the head domain 
whereas the epitope of D9 is in the tail domain the reason why the two lower Mw bands are 
lost from the D9 WB would likely be due to the protein degradation from the C-terminus (i.e., 
the tail domain). However, as only the corresponding highest Mw band is detected by the 
mCherry antibody degradation likely occurs from both sides of the fusion proteins.  
 
4.1.3 Other technical obstacles and limitations  
In case of ICC procedure with antibodies raised against the hDesWT (hDesR350) and the 
mutant (hDesR350P) epitopes additional treatment with 2 M urea was performed (section 
3.1.4, figure 16). The reason for such modification in the standard ICC protocol used with 
other antibodies was due to the necessity for the epitope retrieval. Namely, as the epitope of 
the protein detected by the antibody was located in the coil 2B region it was likely masked 
when the standard ICC procedure was used. Therefore the staining appeared in the form of 
large, punctuated marks located through the cytosol (data not shown). The 2 M urea treatment 
was used in an attempt to denature the coiled coil structure sufficiently to release the epitope 
but not to denature other components in the cell. Further increase in urea concentration or 
additional repetition of rinsing in the 2M urea therefore led to disruption of other cell 
structure, including the native IF network (data not shown). Such procedure has been 
previously successfully applied in ICC analyses of other IF proteins (Franke et al 1983). 
 
Another obstacle during the ICC procedure arose with respect to differentiating C2C12 cells 
on glass cover slips. Namely, as it has been indicated in the original paper of when C2 cell 
line were generated (Yaffe and Saxel 1977), the cells appear to retract or curve up upon 
differentiation whereby they start detaching from the cover slips. Further differentiation on 
collagen-, matrigel- or other forms of coated cover slips was insufficient to keep the 
differentiating cells attached. Finally, activating the glass of the cover slips using the chrome-
sulphuric acid was sufficient to keep a significant proportion of differentiating cells still 
attached to the cover slips. In case of double ICC with MF20-HD1 statistics (section 3.4.5, 
figure 46) the cells were differentiated only for three days prior to the ICC and statistical 
analyses. As MHC is expressed already three days after initiation of differentiation such 
analyses was commonly performed in other studies (such as in Ling et al. 2012a). Therefore, 
as the cell retraction largely started four to five days after initiation of differentiation (data not 
shown) the statistical analyses were performed on the cells fixed after three days of initiation 
of differentiation.  
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With respect to the cell fractionation procedure several other points would need to be briefly 
addressed in this section. One of the points needing some discussion is the use of protein 
concentration in the LIB to scale the loading of the samples on the gel. Although the relative 
amounts of different soluble (i.e., digitonin- or LIB-extracted) protein might differ between 
C2C12 (GM) and (DM) cells the scaling of sample loading to the protein amounts in the LIB 
appeared to have been the best way to do so. Namely, the LIB fractions had the lowest 
amounts of detergents which could interfere with the Bradford assay measurements (digitonin 
also appeared to affect the 595nm absorption of the samples, data not shown) and a relatively 
high amount of protein. As the cell material was collected directly from the Petri dish scaling 
the protein loading to the cell number could have also not been done. 
 
In addition to the fractionation of cells with respect to the solubility of their IF proteins (i.e., 
extractions with the LIB and HIB) an additional extraction using digitonin was performed 
prior to those procedures. Digitonin is a detergent with a sterol moiety which makes it more 
specific to break holes into cholesterol-containing membranes, such as cell plasma membrane 
(Fiskum et al. 1980). Due to such specificity of this detergent the digitonin fractions in the 
procedure would have contained only the most soluble, cytosolic proteins. Therefore as the 
mitotic A-type lamins, which are dispersed throughout the cytosol, would have already been 
extracted in the digitonin fraction those found in LIB of C2C12 (GM) but not of (DM) cells 
do not represent the soluble mitotic lamins in those cells. They would in fact reflect the 
different A-type lamin distribution in the nucleus and hence different chromatin organisation 
in the two stages of the cells.  
 
In addition, one could also address the characteristics of proteins extracted in different 
fractions. The protein remaining in the pellet is considered to be largely IF protein which is a 
part of the filament networks. As it could have been seen (such as in figure 34, section 3.3.4) 
hDesR350P was also extracted only in the pellet fraction. However only a small subfraction 
of cells contained this protein in filaments whereby in higher (above 10) passages almost no 
C2C12 +hDesR350P cells contained HD1-stained filaments (data not shown). However, at 
this higher passage hDesR350P was also only found in the pellet fraction of the cells (figure 
40C, section 3.4.1). Therefore this fraction would appear to contain the other forms of 
insoluble IF-proteins: not only those forming filaments but also those forming compact, 
highly insoluble aggregates. 
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4.2 The impact of the desmin mutants on the endogenous IF network of C2C12 cells 
 
4.2.1 Mild mutants being incorporated into the filaments 
In the work presented two different desmin mutants were analysed and compared to the 
hDesWT. hDesE245D has been previously demonstrated to behave similarly to the hDesWT 
with respect to its filament forming capacities (Bär et al. 2005b). Therefore, it was proposed 
that the effects of this mutation would only manifest themselves in the final stages of the IF 
network formation or in a muscle-type cellular scenario (figure 6B, section 1.3.1). Based on 
the results of the current study (section 3.3.2) one could only point out the differences in its 
distribution in differentiating cells (section 3.4.5). Namely, the percentage of differentiating 
(i.e., MF20-possitive cells) cells which contained HD1-stained filaments was the same in 
those cells compared to the cells transfected with hDesWT. However, some effects of this 
mutant compared to the hDesWT were evident, which is further discussed in section 4.3.1. 
 
Although the transfected hDesE245D was found to form perinuclear accumulations as 
detected by diffuse staining at several instances (one drastic example was given on figure 
28B) it was predominantly found to be integrated into the endogenous filaments (figure 28A). 
These filaments have also colocalised with vimentin IFs (figure 28C). They have persisted 
even in higher (over 15) passages upon transfection and the cells expressing hDesE245D 
appeared only marginally irregular or otherwise different from those in hDesWT-transfected 
cells. 
 
As a matter of fact, the hDesE245D was subsequently found to introduce a cryptic splice site, 
whereby the truncated version, rather than the full length mutant desmin, was concluded to be 
behind the disease phenotype (Clemen et al. 2009). However, there was no clear observation 
that the same occurs in the C2C12 cells. Namely, upon fractionation only a single band 
corresponding to the size of full-length desmin has been detected by both the antibodies 
binding to the head- (HD1) and the other to the tail- (D9) domain (figure 34, section 3.3.4). 
Therefore, the diffuse staining of the hDesE245D was very unlikely due to the presence of a 
putative desmin truncation product.  
 
4.2.2 Asymmetric distribution of severe mutants upon cell division 
On the other hand, the effects of the hDes R350P appear to be far more complex. One of the 
possible causes for such drastic effects of this particular mutation was that the amino acid 
arginine (R) was substituted with proline (P). Whereas arginine contains a side chain with a 
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positively charged guanidinium group at its end, proline is a secondary amine and thereby a 
cyclic amino acid. Due to its cyclic nature the amino acid is characterised by the rigid angles 
and thereby is commonly found in turns between α-helices or β-sheets but not inside them. 
Once located in an α-helix, as the case in this mutant, it introduces a kink in the secondary 
amino acid structure. Yet one should be cautious about extrapolating from these facts. For 
example, another P mutation also occurs in an α-helix, i.e., hDesA360P, and appears to be far 
less deleterious for IF formation as it allows it to get up to the stage of radial compaction 
(figure 6B, section 1.3.1).  
 
Another clear observation, as also documented by several WBs (such as on figure 34, section 
3.3.4), was that the amount of this particular mutant protein is significantly lower in C2C12 
cells than either of the other transfected desmin proteins, hDesWT or the hDesE245D. 
Additional observation (data not shown) was that in later (after 10) passages very few of the 
hDesR350P-transfected cells contained any HD1-possitive IF staining. This was observed in 
each of the several different transfections in the C2C12 cells. In each the protein was lost by 
further cell passaging. Some of the possible causes for such effect could be due to the mutant 
degradation or its lower expression and different distribution. However, as the observation 
was recurrent in different transfection experiments, and was only observed with this particular 
mutant, its lower expression or varied distribution in different cells seem to be unlikely as 
potential causes. To confirm that the observations were indeed the result of hDesR350P 
transfection plasmid DNA the Vim-/- fibroblasts were used as a positive transfection control. 
The experiment has demonstrated that upon transfection of hDesR350P into these cells its 
distribution was distinctly different in all cells as compared to that obtained with the hDesWT 
transfection (compare in figure 37A and B, section 3.3.6).  
 
What has been extensively presented in the section 3.3.3 was the apparent asymmetric 
distribution of hDesR350P in different transfected C2C12 cells. As the phenotype could have 
occurred due to asymmetric distribution upon cell division or different extent of mutant 
protein degradation and/or expression it was labelled with a neutral term in order not to 
presuppose the actual cause behind it. Attempts for live cell imaging of the mCherry-tagged 
hDesR350P failed (section 3.3.5) and hence the cause behind the phenotype could not have 
been determined. Furthermore, no quantitative analyses could be obtained due to the further 
variability with respect to the phenotype itself. Namely, the variable distances between the 
pairs of cells manifesting the observed phenotype or minor differences in local staining 
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efficiency with either HD1 or D9 antibodies hindered the attempts to statistically analyse the 
observations. Therefore the data has been presented at length (section 3.3.3) in order to 
indicate the observed heterogeneity and to describe it as thoroughly as possible.  
 
4.2.3 The mutant desmin protein is not entirely segregated from the wt one 
With respect to one of the main topics of this work, the question of desmin mutant segregation 
from the wt protein, one could extrapolate on the data obtained. Namely, at a ratio 1:3 
(hDesWT/R350P) the hDesR350P was still found to have a dominant negative effect on 
desmin filaments formation in vitro (Bär et al. 2005a). Furthermore, the phenotype of the 
hDesR350P transfection in Vim-/- fibroblasts is distinctly different from that of the hDesWT, 
indicating that the observed filament formation capacity of the hDesR350P observed in 
C2C12 cells is not intrinsic for the protein itself. hDesR350P was also found to form 
filaments with the endogenous vimentin protein (figure 31B and D, section 3.3.3) indicating it 
is not entirely segregated from the endogenous desmin or vimentin IF networks. The likely 
reason for the discrepancy between the observations in the two cell lines could be due its 
capacity to coassemble with the endogenous vimentin and/or desmin IFs.  
 
However, the question of the mechanisms a muscle cell has to cope with the deleterious 
effects of the mutation still remains open. Namely, the phenotype of the hDesR350P 
discussed in detail indicates that the cells have difficulties coping with the effects of the 
mutated protein. As the cells do appear to form both desmin and vimentin IFs which contain 
hDesR350P the in vivo data would suggest that the hDesWT and the hDesR350P proteins are 
at least not fully segregated one from the other.  
 
However, the data obtained by IP (figure 38, section 3.3.7) could argue differently as the 
mDes was not co-IPed with the hDes variants. As that was also the case with the hDesWT IP, 
the likely cause for this apparent segregation might simply be in different timing of the 
transcription and translation, and thereby dimer and tetramer assembly, of endogenous and 
transfected desmin. Namely, as the gene promoter of the transfected desmin gene (β-actin 
promoter) is different than that of the endogenous one, the transcription and subsequently 
translation of the two desmin variants would not necessarily occur at exactly the same time. 
Thereby, the smaller units of the IFs (i.e., such as tetramers) would be assembled from 
predominantly single desmin species. Finally, one should also note that no hDesR350P was 
detected in the IP of the respective sample. The cause for this apparent lack of the bound 
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protein could be due to the effect of a very low amount of hDesR350P already in the RIPA 
sample (figure 38, section 3.3.7). The previous data on the effects of increasing the amount of 
hDesR350P on assembly of hDesWT IFs (Bär et al. 2005a) indicate that the two species could 
form higher order structures in vitro at particular ratios. Although the results from the IP 
would argue the opposite occurs in cells one should be cautious about interpreting these data 
since in the IP of the hDesWT no endogenous mDesWT was co-IPed either.  
 
4.3 Differentiation of C2C12 cells expressing mutant desmin 
 
Before discussing the effects of the desmin mutations on C2C12 cell differentiation one 
should also briefly address the issue of plasmid choice for the analyses. Initially pHβAPr-1-
neo plasmid appeared appropriate as it was designed for genes which need to be constitutively 
expressed as it contained a β-actin gene promoter (Gunning et al. 1987). However, β-actin 
mRNA is downregulated in differentiating C2C12 (Shimokawa et al., 1998) indicating that 
upon differentiation the expression of the hDes mRNA might also decrease. Yet as reported in 
the original paper (Gunning et al. 1987) the gene expression from this vector is not affected 
by C2C12 differentiation. Nevertheless, all of the presented analyses of the differentiating 
cells containing the transfected desmin mutants were compared to the ones from hDesWT-
transfected C2C12 cells. 
 
4.3.1 Effects of G9a inhibitor and geneticin treatments onto C2C12 differentiation  
Due to the loss of hDesR350P from the cells during differentiation we have also attempted 
differentiating the cells in the presence of the selection marker, G418. Thereby the 
differentiating cells would have likely retained the protein more efficiently than without the 
drug, which might appear to be the case for C2C12 +hDesE245D cells (figure 40, section 
3.4.1). On the other hand, the total amount of desmin in C2C12 +hDesR350P (DM+G418) 
cells is several fold higher than in the (DM) ones whereas the amounts of the transfected 
desmin are comparably similar. This result indicates that although the overall amount of 
hDesR350P in these cells is somewhat higher the relative (i.e., the percentage of the total) 
amount of it is lower. Such effect could arise due to the difference in differentiation as C2C12 
(DM) express several fold higher amounts of desmin as compared to the (GM) cells (figure 
21, section 3.2.2). With respect to the number of HD1- and MF20- double positive cells 
treatment of cells with G418 appeared to have opposite effects on different cell lines. Namely, 
Discussion 
 
78 
 
whereas in case of the hDesWT and hDesE245D-transfected cells the fraction of double-
positive cells increased or remained the same, in the differentiating cells in hDesR350P it was 
reduced compared to the respective untreated differentiating cells.  
 
Another drug that has been implemented in the current study is an inhibitor of G9a 
methyltransferase, BIX-01294 (bix). In addition to its role as a histone methyltransferase, G9a 
maintains myoblasts in undifferentiated state by methylating MyoD (as described in Ling et 
al. 2012a). The same study reported its use for a control reagent added to the cells to enhance 
their differentiation. There have been additional studies demonstrating other effects of BIX-
01294 on muscle cell differentiation (Ling et al. 2012b), as well as on differentiation of other 
cell types (Culmes et al. 2013), indicating that the drug could be a powerful tool in driving the 
cells into differentiation. In order to attempt to enhance the differentiation of transfected 
C2C12 cells the drug was used in a subset of experiments. The treatment with the drug did not 
appear to lead to higher expression of desmin except in the case of C2C12 +hDesR350P cells 
(figure 39C, section 3.4.1), which would have been one of the indicators of more efficient 
differentiation. On the other hand, the overall expression of the differentiation marker MHC 
either remained the same, as in case of the C2C12 cells transfected with either of the desmin 
mutants, or was even lower, as in case of the untransfected and hDesWT transfected cells, as 
compared to the untreated cells (figure 45, section 3.4.5).  
 
However, the most drastic effect of the drug treatment was with respect to the amount of 
HD1- and MF20-double positive cells in case of the C2C12 expressing the mutant proteins 
(figure 46, section 3.4.4). One should also note that there was a significantly higher 
fluctuation in the number of double positive cells among C2C12 +hDesE245D (DM 
+bix/+G418) compared to the other samples (note the errors bars on figure 46). As the BIX-
01294 drug has been implemented in trace amounts (2.5nM) one could speculate about a 
stochastic effect of the drug whereby only a subpopulation of the cells would have received 
the efficiently effective treatment.  
 
The reduction of the number of HD1- and MF20-double positive cells among C2C12 
+hDesE245D by BIX-01294 treatment might be caused by the marginally better efficiency of 
cells without the transfected protein to better differentiate as opposed to the cells expressing 
the mutant desmin. This point is further supported by the effects the drug has on hDesR350P-
transfected cells as the drug treatment also led to the reduction of the number of MF20- and 
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HD1-double positive cells. However, one should also note that G9a is a histone 
methyltransferase whereby its inhibition could also lead to other effects on the chromatin as 
its role is not limited to the genes and factors involved in muscle cell differentiation. In 
addition, it should also be noted that the increase of the amounts of BIX-01294 5-fold in the 
course of a 6-day differentiation experiment appeared to completely inhibit differentiation as 
determined by the cell morphology (data not shown). 
 
4.3.2 Presence of hDesR350P could stimulate either differentiation or cell proliferation in 
C2C12 cells 
In the final points of the discussion on the presented results one could outline the general 
phenotype of the cells transfected with the mutant hDesR350P and thereby propose the 
mechanism of causing such effects in the transfected cells. On the one hand, the hDesR350P, 
unlike hDesWT and the hDesE245D variants, appears to stimulate the cell proliferation or 
their delay in differentiation-associated changes. This conclusion is evident from the fact that 
their distribution of A-type lamins upon fractionation does not appear to change significantly 
upon induction to differentiation (figure 44, section 3.4.3) as compared to the other 
transfected cells. The amount of more soluble (i.e., LIB and Sup-extracted) A-type lamins is 
nevertheless relatively lower in DM C2C12 +hDesR350P cells, as compared to the respective 
GM cells. This difference indicates that the failure to change their A-type lamin distribution, 
which appears to accompany differentiation (as in figures 19 and 20, section 3.2.1), might 
also reflect the state of only a subset of cells. 
 
On the other hand, the amounts of MHC in cells transfected with either of the desmin mutants 
were higher than in untransfected or hDesWT-transfected cells (figure 45, section 3.4.4). 
Therefore, whereas on the one hand presence of hDesR350P in these cells would appear to 
delay their differentiation (A-type lamins fractionation results) it would also appear to 
stimulate their differentiation (the amount of MF20 in cell extracts). The low percentage of 
HD1- and MF20-double positive C2C12 +hDesR350P cells further suggest a possible link 
between the two apparently opposite results. Namely, on the one hand some of the cells in a 
population would appear to retain the mutant protein and they appear to be inefficient in 
promoting differentiation. On the other hand the cells with low amounts of this particular 
mutant protein have a higher chance to differentiate. These cells could be differentiating even 
more efficiently than the untransfected or hDesWT-transfected cells, as indicated by the 
higher amounts of total MHC in the cells transfected with the desmin mutants (figure 45, 
section 3.4.4).  
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These conclusions would also correlate to what is observed with mutants in other proteins 
causing related diseases. Such is the case with lamin A mutants causing Emery-Dreifuss 
muscular dystrophy which appear to inhibit in vitro differentiation of C2C12 cells (Favreau et 
al. 2004). Thereby one could conclude that in order to attempt to dispose of the mutant 
desmin protein, the cells expressing it would need to delay their differentiation. An effect 
analogous to the proposed model was also observed with the treatment of cultured myoblasts 
and myotubes with prion toxic peptide, PrP106-126 (Brown et al. 1998). The toxicity of this 
peptide was considerably higher in myotubes as compared to the myoblasts. Such an 
observation could be explained by the fact that the myoblasts, unlike myotubes, are 
undergoing cell proliferation whereby they could discard the toxic or aggregation-prone 
peptides through the process of cell division. A further support in favour of such hypothesis 
comes from the studies of treating astrocytes with the same peptide. Namely, in case of these 
cells, treatment with this peptide also induces a release of cytokines and thereby stimulates 
astrocyte proliferation. These studies would indicate that presence of some aggregation-prone 
proteins, such as some desmin mutants in this case, could delay differentiation by induction of 
cell proliferation. Thereby, as in case of the lamin A mutant, which causes Emery-Dreifuss 
Muscular Dystrophy (Favreau et al. 2004), desmin mutants might also delay differentiation.  
 
4.4 Conclusions and the outlook 
 
The final conclusion from the study, as discussed in the previous section, is that the effects of 
the presence of hDesR350P mutant in myoblasts could have opposite effects on the cell 
differentiation. The asymmetric hDesR350P distribution in transfected myoblasts further 
suggests a model of how this double effect could occur whereby the cells accumulating the 
mutant protein would fail to differentiate. On the other hand, accumulation of mutant protein 
in only a subpopulation of cells could give rise to a fraction of mutant-free cells. Once these 
cells fuse they would nevertheless still be expressing the mutant protein which could start 
accumulating over time and, given the late onset of the disease, eventually lead to the fatal 
phenotypes. Yet one should bear in mind that the presented data were obtained from a cell 
culture model scarcely mimicking the actual situation in the adult muscle cells. For example, 
the loss of hDesR350P from cells by further passaging indicates a strong toxic effect of the 
protein on the cell viability. However, having a subpopulation of C2C12 cells still integrating 
the mutant into their endogenous IFs indicates that the cells do have some innate mechanisms 
which would allow them to tolerate the mutant protein.  
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Therefore, additional support for the proposed mechanisms and further elucidation of the 
actual mode of pathogenesis are still needed. To achieve that one should first attempt to 
generate a mutant desmin protein fused to a fluorescent tag which could be used for the live 
cell imaging. In addition, one would also need a more specific mDes antibody to be able to 
precisely differentiate the two species of desmin, the hDesWT and the transfected mutants. In 
that respect, another alternative to perform further experiments in more native conditions 
would be to subclone the hDes epitope of HD1 into mDes sequence. This form of fusion 
protein could be subsequently used for transfection into C2C12 cells. As previously indicated, 
the same set of experiments using the hDesA360P mutant could also be performed as 
additional control. Finally, the experiments so far were performed on a cell culture model and 
the results were attempted to be correlated to the observations on the samples from 
desminopathies patients. Thereby similar analyses could be performed on the heterozygous 
and homozygous mDesR349P knock-in mice (group of Prof. Rolf Schröder, Neuropathology 
institute, Erlangen). By pursuing such analyses one would get a more reliable insight into the 
actual pathogenesis process in the case of desminopathies.  
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6. Appendices 
 
Appendix 1: List of abbreviations 
 
%    Percent 
oC    Degree Celsius  
μg, μl, μM   Micro-gram, -liter, -molar 
Bix    BIX-01294 
C2C12 +hDesmin  C2C12 stably expressing a particular hDesmin variant  
CD    Consensus domains/motifs  
conc.    Concentration  
DAPI    4´-6-Diamidino-2-phenylindol 
ddH2O    Double-distilled water 
DGC    Dystrophin-glycoprotein complex  
DM    Differentiation medium 
DNA     Deoxyribonucleic acid 
E. Coli    Escherichia Coli 
EM    Electron microscopy 
FCS     Fetal calf serum 
fr.    Fraction (of antibody eluate)  
GAPDH   Glyceraldehyde-3-Phosphate Dehydrogenase 
GFAP    Glial fibrillary acidic protein  
GM    Growth medium  
h    Hour  
hDes    Human desmin 
HE    Hematoxylin-eosin 
HGPS    Hutchinson-Gilbert progeria syndrome  
HRP    Horse radish peroxidise  
ICC    Immuno-cytochemistry 
IF    Intermediate filaments 
INM    Inner nuclear membrane 
IP    Immunoprecipitation   
mCherry-hDes  mCherry-tagged hDes (N-terminally)  
mDes    Mouse desmin 
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m/hDes   Mouse and/or human desmin 
min    Minute 
MF    Microfilaments 
MFM    Myofibrillary myopathy  
MHC    Myosin heavy chain  
monoAb   Monoclonal antibody  
ms    Mouse 
MT    Microtubules  
Mw    Molecular weight  
ONM    Outer nuclear membrane  
p.    Passage  
PCD    Pre-coil domain  
PCR    Polymerase chain reaction 
pH     Power of hydrogen (concentration of hydrogen ions in solution) 
polyAb   Polyclonal antibody 
rb    Rabbit  
RT    Room temperature  
s    Second  
SHC    Sequence homology classes  
ULF    Unit length filament 
WB    Western blot  
WT    Wild type (i.e., normal)  
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Appendix 2: h/mDesmin amino acid sequences alignment  
 
Sequence alignment of amino acid composition of mouse and human desmin proteins. The 
amino acids that were the same in the two sequences have grey background whereas the ones 
that differ, with the same or different type of chemical group in the amino acid, are labelled in 
red and yellow respectively. One amino acid difference (hDesminS81) has green background.  
 
        1                                                   50 
mDesmin MSQAYSSSQR VSSYRRTFGG APGFSLGSPL SSPVFPRAGF GTKGSSSSMT  
hDesmin MSQAYSSSQR VSSYRRTFGG APGFPLGSPL SSPVFPRAGF GSKGSSSSVT  
 
        51                                                 100 
mDesmin SRVYQVSRTS GGAGGLGSLR SSRLGTTRAP .SYGAGELLD FSLADAVNQE  
hDesmin SRVYQVSRTS GGAGGLGSLR ASRLGTTRTP SSYGAGELLD FSLADAVNQE  
 
        101                                                150 
mDesmin FLATRTNEKV ELQELNDRFA NYIEKVRFLE QQNAALAAEV NRLKGREPTR  
hDesmin FLTTRTNEKV ELQELNDRFA NYIEKVRFLE QQNAALAAEV NRLKGREPTR  
 
        151                                                200 
mDesmin VAELYEEEMR ELRRQVEVLT NQRARVDVER DNLIDDLQRL KAKLQEEIQL  
hDesmin VAELYEEELR ELRRQVEVLT NQRARVDVER DNLLDDLQRL KAKLQEEIQL  
 
        201                                                250 
mDesmin REEAENNLAA FRADVDAATL ARIDLERRIE SLNEEIAFLK KVHEEEIREL  
hDesmin KEEAENNLAA FRADVDAATL ARIDLERRIE SLNEEIAFLK KVHEEEIREL  
 
        251                                                300 
mDesmin QAQLQEQQVQ VEMDMSKPDL TAALRDIRAQ YETIAAKNIS EAEEWYKSKV  
hDesmin QAQLQEQQVQ VEMDMSKPDL TAALRDIRAQ YETIAAKNIS EAEEWYKSKV  
 
        301                                                350 
mDesmin SDLTQAANKN NDALRQAKQE MMEYRHQIQS YTCEIDALKG TNDSLMRQMR  
hDesmin SDLTQAANKN NDALRQAKQE MMEYRHQIQS YTCEIDALKG TNDSLMRQMR 
 
        351                                                400 
mDesmin ELEDRFASEA NGYQDNIARL EEEIRHLKDE MARHLREYQD LLNVKMALDV  
hDesmin ELEDRFASEA SGYQDNIARL EEEIRHLKDE MARHLREYQD LLNVKMALDV  
 
        401                                                450 
mDesmin EIATYRKLLE GEESRINLPI QTFSALNFRE TSPEQRGSEV HTKKTVMIKT  
hDesmin EIATYRKLLE GEESRINLPI QTYSALNFRE TSPEQRGSEV HTKKTVMIKT  
 
        451               470 
mDesmin IETRDGEVVS EATQQQHEVL  
hDesmin IETRDGEVVS EATQQQHEVL  
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Appendix 3: Amino acids 
 
Amino acid  three-letter code single-letter code 
_____________________________________________ 
 
Glycine  Gly    G 
Proline   Pro    P 
Alanine   Ala    A 
Valine   Val    V 
Leucine   Leu    L 
Isoleucine   Ile    I 
Methionine   Met    M 
Cysteine   Cys    C 
Phenylalanine  Phe    F 
Tyrosine   Tyr    Y 
Tryptophan   Trp    W 
Histidine   His    H 
Lysine   Lys    K 
Arginine   Arg    R 
Glutamine   Gln    Q 
Asparagine   Asn    N 
Glutamic Acid  Glu    E 
Aspartic Acid  Asp   D 
Serine    Ser    S 
Threonine   Thr   T 
 
